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ALT Alanine Aminotransferase 
AP Auricularia polytricha 
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Abbreviations 
GLC Gas Liquid Chromatography 
Glc Glucose 
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Man Mannose 
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Heart disease is the second leading cause of death in Hong Kong. Moreover, 
hyperlipidemia is a common health problem that strongly associated with cardiovascular 
diseases such as atherosclerosis and coronary heart disease. Although there are many 
factors leading to these diseases, a strong relationship between low density lipoprotein 
cholesterol (LDL-C) concentration and extent of coronary atherosclerosis has been 
shown in many studies. Moreover, there is an inverse relationship for high density 
lipoprotein cholesterol (HDL-C). 
All fungal walls contain a mixture of fibrillar and matrix components. For the 
matrix components, it includes various polysaccharides that can serve as dietary fiber 
and that of water-soluble one are more important which include gums, pectins and 
psyllium. Dietary fiber has been reported with hypocholesterolemic effects. Water-
soluble polysaccharide was extracted from flingus Auricularia polytricha and its 
hypocholesterolemic and antiatherosclerotic effects was studied. 
Polysaccharide was extracted by hot water. Then, it was studied by ethanol 
precipitation and size exclusion chromatography, a heterogeneous mixture of 
polysaccharide was found in this fungus. By HPLC analysis of its monosaccharide 
composition, it was predicted to contain mainly glucomannans and galactomannans. The 
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Abstract 
composition of crude APP, APP-A and APP-B were similar. The results showed that 
there is no toxic effect of APP to liver by measuring AST and ALT activity. 
In our study, Golden Syrian Hamster was used as animal model. In experiment 1， 
the protective effect of APP from hypercholesterolemia was studied. Normal hamsters 
was fed with high cholesterol diet with supplementation of APP. Liver cholesterol, 
plasma total cholesterol and HDL-cholesterol were decreased significantly in the test 
groups. Therefore, APP can protect hamster from hypercholesterolemia. Moreover, it 
can increase both neutral and acidic sterols excretion with small difference for neutral 
sterol. In experiment 2, the therapeutic effect of APP from hypercholesterolemia was 
studied. Hamsters were boosted into hypercholesterolemic state for four weeks and then 
it was fed with diet with supplementation of APP. Similar results with experiment 1 
were obtained and APP was shown to lower the cholesterol level of hamster with 
hypercholesterolemia. In experiment 3, the dose response of APP was studied. Increased 
amount of APP supplementation can lower hepatic cholesterol and LDL-cholesterol 
level. However, only hepatic cholesterol showed a dose response with APP. Moreover, 
APP can also increase the steroids excretion but do not show any dose-dependent 
response. In experiment 4 and 5, short chain fatty acids (SCFA) were shown to have 
hypocholesterolemic effect by lowering hepatic cholesterol and LDL-cholesterol. By 
measuring the activity of HMG-CoA Reductase, SCFA and APP were reported to lower 
the de novo cholesterol synthesis by lowering the activity of enzyme. Polysaccharides 
may be fermented by colonic bacteria to produce SCFA. Therefore, parts of 
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hypocholesterolemic effect of APP may due to the action of by-product SCFA. In 
experiment 6, the antiatherosclerotic effect of APP was studied. Atheroma was stained 
by Sudan III and the area of atherosclerosis was calculated. APP was reported to 
decrease the degree of atherosclerosis. In all experiments, APP has no effect on plasma 
triglyceride level. 
Results have shown that the hypocholesterolemic effects of APP were due to 
decrease in de novo cholesterol synthesis and increase the excretion of sterols in feces. 
However, further experimental investigations were needed to elucidate the detail 
mechanisms such as the fermentation of polysaccharide and the binding of 
polysaccharide to sterols. Moreover, the activity of cholesterol-7-alpha-hydroxylase was 
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Many studies were claimed on the possible involvement of dietary fibers in the 
occurrence of cardiovascular disease (Veldman et al, 1997), several epidemiological 
observations (Cheng et al, 1999) have suggested that a low dietary fiber intake is 
associated with a higher incidence of coronary heart disease (CHD) (Kromhout et al, 
1982). 
In fact, the modem western diet is generally poor in fiber (15-20 g/d) and rich in 
fat (38-45% energy) and cholesterol (up to 0.5 g/d). On the contrary, the Stone-age diet 
(35-15,000 y ago) which is well representative of the dietary environment which 
determined the collective human genome was poor in fat (20-25% energy) and basically 
rich in dietary fiber (40 g/d and above). 
Given the documented association of blood lipid and lipoprotein levels (Chait et 
喊 1993; Cleeman, 1997) with the risk of coronary heart disease, research has mainly 
been focused on the possible alternations and improvement of lipid metabolism by 
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dietary fiber (Menon & Kump, 1976; Mcintosh et al, 1991). Whether dietary fibers 
affect lipid metabolism and how dietary fibers can exert such effects has been the matter 
of several hundreds of studies all over the world during the last three decades. 
1.2 Classification of Plant Polysaccharides 
Plant polysaccharides may be separated into two broad categories (Hans & 
Geoffrey, 1996). Starch, a ubiquitous storage polysaccharide, is an a-linked glucan and 
is the major carbohydrate of dietary staples such as cereal grains and potatoes. The 
nonstarch polysaccharides (NSP) of plants, such as cellulose, pectin, and hemicellulose, 
are non- a-glucan polysaccharides. The NSP tend to have a structural function and are 
the principal components of the plant cell wall. Recently NSP have become the objective 
in the measurement of dietary fiber. 
Because of its a-glucosidic linkages, starch is susceptible to hydrolysis by 
pancreatic a-amylase. In contrast，NSP completely resist digestion by the enzymes 
secreted into the small intestine of man. 
Before a decade, starch was thought to be entirely digested while NSP entirely 
resisting digestion in the small intestine. However, it is now clear from a number of 
studies in man (Englyst & Cummings, 1988a; Englyst & Cummings, 1985) and animals 
(Millard & Chesson，1984) that this is not the case and that a significant proportion of 
2 
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dietary fiber may pass intact into the colon, where it becomes available for fermentation 
by gut bacteria. In addition, for some animals a considerable amount o fNSP (and starch) 
may be fermented in the small intestine. 
1.2.1 Definition of Dietary Fiber 
Dietary fiber can be classified into water-soluble DF and water-insoluble DF and 
it is defined as the “plant polysaccharides and lignin which are resistant to hydrolysis by 
the digestive enzymes of man". However, some starch may also escape or resist to 
hydrolysis of digestive enzymes. Therefore, for analytical purposes dietary fiber should 
be defined as the sum of the nonstarch polysaccharide (Englyst & Cummings，1988b). 
Since lignin is not a polysaccharide, it is not included in the definition of dietary fiber. 
1.2.2 Types of Soluble Dietary Fiber 
Several reviews document the hypocholesterolemic effects of soluble fibers in 
humans and the lack of effect of insoluble fiber (Story et al, 1997). Examples of 
insoluble fiber included cellulose, hemicellulose, resistant starch and chitin. The 
following are the examples of water-soluble fiber: 
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Gums 
Guar gum, a glucomannan or galactomannan extracted from the endosperm of 
the Indian cluster bean, has been used extensively in clinical studies. Glucomannan 
appears to be linear polymers with both mannose and glucose in the chain. The ratio of 
mannose to glucose is between 1:1 and 2.4:1. Hardwood glucomannans appear to 
contain no galactose and are relatively insoluble, but the glucomannans from 
gymnosperms have galactose side chains and a higher mannose to glucose ratio (3:1). 
The presence of side chains tends to make these polysaccharides more soluble in water, 
possibly because the side chains prevent the formation of intermolecular hydrogen 
bonding. Glucomannans are part of the hemicellulose fraction of the plant cell wall. 
Guar gum appears to be a good model with which to examine the effect of 
increased luminal viscosity on small intestine fiinction. It can also reduce plasma total 
cholesterol and LDL-cholesterol but with no effect on HDL-cholesterol and triglyceride 
(Topping, 1994). Guar gum slows the rate of diffusion of cholesterol mixed micelles in 
vitro at concentration as low as 0.25% (Phillip, 1986). It appears to inhibit convection 
effects of intestinal movements. In vivo it binds or entraps bile acids (Gallaher & 
Schneeman, 1986). Several studies were also reported of increased bile acid excretion 
with guar gum. 
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Pectins 
The most widespread soluble dietary fiber structure in foods is pectin, a 
polygalacturonic acid found in fruits, vegetables, legumes, and roots (sugar beets and 
potatoes) as storage polysaccharide. Pectin is the general term designating those water-
soluble pectinic acids of varying methylester content and degree of neutralization which 
are capable of forming gels with water and acid under suitable conditions. Pectin is 
found in the primary cell wall and intracellular layer. It changes from an insoluble 
material in the unripe fruits to a much more water-soluble substance in the ripe fruit. Its 
ability to form gels and its ion binding capacity may be important in human nutrition. 
Pectins was claimed to have significant hypocholesterolemic effects (Reiser, 1987) with 
no influence on plasma triglyceride level. It shares many properties with the gums. 
Psyllium 
Psyllium hydrophilic mucilloid, a highly branched acidic arabinoxylan extracted 
from the husk of Plantago ovata seeds grown in Asia, has been widely used for 
management of large intestine disorders for more than 50 years. Past studies have been 





Oatmeal and oat bran are rich in the water-soluble p-glucan or oat gums, which 
have significant hypocholesterolemic effects. P-glucan is a glucose polymer consisting 
of P-linked glucose molecules, with a mixed linkage, i.e., some (3-1,3-linkages 
interspersed with the p-l,4-linkages. 
Oat products have the characteristic of selectively decreasing serum LDL-
cholesterol (Kirby et al, 1981) while preserving or actually increasing serum HDL-
cholesterol, leading to significant and favorable reduction in the LDL: HDL-cholesterol 
ratio. Thus, in addition to a low-fat and low-cholesterol diet, regular use of oat products 
may have an important role in reducing risk for coronary heart disease (Anderson & 
Gustafson, 1988). 
1.3 Physiological Effect of Fiber 
Ingestion of a diet rich in dietary fiber may result in slower gastric emptying, 
delayed absorption in the small intestine, faster colonic transit, and an increased stool 
output (Anderson, 1985). These effects，however, are dependent on the type of dietary 
fiber ingested. The plant polysaccharides that make up dietary fiber have a variety of 
chemical structures and physical properties. The soluble polysaccharides form viscous 
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solutions in the intestine lumen and delay absorption of nutrients in the small intestine 
(Rosado & Diaz, 1995). Many of these soluble polysaccharides are extensively 
fermented in the proximal colon and have minimal effects on stool output. In contrast, 
the insoluble polysaccharides act as indigestible solids and have little effect on small 
intestine physiology. However, they are more resistant to bacterial degradation and have 
a greater influence on stool output and colonic transit. 
1.3.1 Reduction in Absorption by Viscous Polysaccharides 
The addition of viscous polysaccharides to carbohydrate meals reduces 
postprandial hyperglycemia (Wursch & Pi-Simyer, 1997), indicating an impairment of 
carbohydrate absorption. The rate of absorption was slowed but that the total amount 
absorbed was not reduced. There is also a malabsorption of lipids after pectin ingestion. 
1.3.2 Gastric Emptying 
In general, viscous polysaccharides slow the emptying of liquids from the 
stomach, and this effect was thought to be responsible for the reduced rate of absorption 
of rapidly absorbed substance (Holt et al, 1979). However, there is no correlation 
between the rate of gastric emptying and postprandial plasma glucose levels after 
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administration of guar gum, which suggests that the action of viscous polysaccharides on 
gastric emptying may not be the dominant factor in reducing postprandial glycemia. In 
fact, at low concentration, some viscous polysaccharides, such as locust bean gum, 
accelerate gastric emptying but still depress postprandial glycemia. 
1.3.3 Effect of Viscous Polysaccharides on Intraluminal Mixing 
Two mechanisms bring nutrients into contact with the epithelium where they are 
absorbed. First, intestinal contractions create turbulence and convective currents, which 
mix the luminal contents and bring material from the center of the lumen close to the 
epithelium, and second, nutrients have to diffuse across the thin relatively unstirred layer 
of fluid lying adjacent to the epithelium (Blackburn et al, 1984). Viscous 
polysaccharides could reduced intestinal absorption by reducing mixing and/or diffiision. 
Viscous polysaccharides have been shown to increase the apparent thickness of the 
unstirred layer. The unstirred layer, however, is not an anatomic reality but a functional 
concept that has been invented to explain the changes in absorption that occur under 
stirred or less stirred conditions. An increase inmstirred layer thickness could imply a 
decrease in the diffusion coefficient for the test solute across an unstirred layer of 
unchanged thickness, or it could imply a reduction in luminal convection causing an 
actual increase in the unstirred zone. 
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1.3.4 Effect of Luminal Secretions on Viscosity 
Because the reduction in intestine absorption by soluble fibers is related to 
viscous properties, it is important to consider the effect of intestinal secretions on the 
viscosity of ingested plant polysaccharides. 
1.4 Physicochemical Qualities and Hypocholesterolemic Effects 
Many of the physiochemical characteristics of fibers affect their 
hypocholesterolemic properties. Some of the important physicochemical properties of 
dietary fibers (Chau & Cheung，1999) are the following: particle size, preparation and 
surface area; water-holding capacity; solubility features including viscosity and gelling 
properties; binding properties including ion exchange and absorption of organic 
molecules; and degradability including fermentation by bacteria (Dreher, 1987). 
Smaller particles may have greater bile-acid-binding capacity but increase fecal 
bulk less than larger particles. Water-holding capacity may relate to viscosity and gelling 
characteristics but does not have a defined role in the hypocholesterolemic effects of 
dietary fiber. 
The viscosity and gelling properties of soluble fibers may have important effects 




increase the viscosity of intestine contents or that produce gels may decrease intestinal 
mobility, thereby decreasing the mixing of nutrients, digestive enzymes and other 
intestinal components required to interact for optimal micelle formation and absorption 
(Schneeman, 1987). Decreases in intestinal mobility may decrease bile acid pool size 
because of decreasing absorption rate. 
The physicochemical properties of pectins are better characterized than most 
other fibers and correlate with their hypocholesterolemic potential. In general, the large-
molecular-weight pectins with more extensive esterification of uronic acid groups with 
methyl groups decrease serum cholesterol more than lower-molecular-weight, lower-
methoxylated pectins 
The binding properties of dietary fibers may affect the absorption of cholesterol, 
fatty acids, and bile acids. Wheat bran and cabbages, for example, have high cation-
exchange capacities, whereas psyllium and cellulose have low capacities (Dreher, 1987). 
Whereas dietary fibers with ion-exchange properties have cation-exchange properties, 
the therapeutic bile-acid-binding resins such as ©Cholestyramine and colestipol are 
strong anion-exchange resins. Thus, it seems unlikely that the ion-exchange properties of 
dietary fibers have an important effect on bile acid binding and excretion. It seems more 
likely that the organic-binding characteristics and viscosity-gelling properties of fibers 
are important in altering the absorption and metabolism of bile acids (Selvendran, 1987). 
Most dietary fibers are partially fermented by bacteria in the human colon, and 
some, such as pectin, are almost completely fermented. Fermentation products include 
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hydrogen, carbon dioxide, methane, water and short chain fatty acid (SCFA) such as 
acetate, propionate and butyrate. These SCFA are almost completely absorbed from the 
colon and may affect hepatic cholesterol synthesis (Chen et al, 1984). In addition, the 
presentation of more dietary fiber to the colon stimulates the growth of more bacteria, 
leading to further conversion of primary to secondary bile acids. 
1.5 Gastrointestinal Events and Hypocholesterolemic Effects 
Dietary fibers have major effects on gastrointestinal functions, resulting in 
alterations in absorption of nutrients, altered hormonal responses and production of 
SCFA (Rosado & Diaz，1995). These event could act individually or collectively to 
decrease serum cholesterol. The effect of dietary fiber on different segments of the 
gastrointestinal tract can be examined to explore potential mechanisms by which dietary 
fiber may decrease serum cholesterol. 
1.5.1 Mouth 
High-fiber foods are less energy dense. Although not extensively studied, high-
fiber foods appear to produce greater satiety between meals than low-fiber foods 
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(Blundell & Burley, 1987). These event may lead to lower energy intake and slight 
reductions in body weight, which could produce small reductions in serum cholesterol. 
1.5.2 Stomach 
Soluble fibers tend to delay gastric emptying which may contribute to earlier 
fullness and satiation leading to decreased energy intake. 
1.5.3 Small intestine 
Through their viscosity and gelling properties, soluble fibers may delay or even 
decrease the digestion and absorption of nutrients. These effects could be mediated by 
decreasing the mixing of intestinal contents, decreasing intestinal mobility, and 
increasing the unstirred water layer, presenting a physical barrier to nutrient absorption. 
Certain fibers increase small intestinal transit, whereas others may slow small ntestinal 
transit，providing less or more time for nutrient absorption. Dietary fibers may affect 
small intestinal cell function through morphological and cell proliferation effects. These 
various effects could independently affect cholesterol homeostasis or work in 
combination with other effects. 
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1.5.4 Large intestine 
Dietary fibers have well-documented effects on fecal weight, stool frequency, 
transit time, and intraluminal pressures. These effects may not be important in 
cholesterol metabolism, since wheat brans, one the most active effectors of these events, 
does not lower serum cholesterol. More important, it seems that the proliferation of 
colonic bacteria and their metabolic processes and produce such as conversion of 
primary to secondary bile acids and short-chain fatty acid production contribute 
substantially to the hypocholesterolemic effect of dietary fiber. 
1.6 Proposed Mechanisms for Hypocholesterolemic Effects 
Although numerous investigators have documented the cholesterol-lowering 
effects of dietary fiber, the mechanisms responsible for these effects remain unclear. 
Several hypothesis have emerged regarding the cholesterol-lowering mechanism, 
including these: (1) fiber may alter bile acid absorption and metabolism; (2) fiber may 
modify lipid absorption and metabolism; (3) short-chain fatty acid (SCFA) resulting 
from fiber fermentation may affect cholesterol or lipoprotein metabolism; and (4) fiber 
may change insulin or other hormone concentrations or tissue sensitivity to hormones. 
13 
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1.6.1 Altered Bile Acid Absorption and Metabolism 
One of the earlier hypotheses concerning the hypocholesterolemic effect of 
dietary fiber suggested that fiber could bound bile acids and increased their fecal 
excretion. Thus, more hepatic cholesterol was needed for bile acid synthetic pathways, 
and there was less cholesterol available for lipoprotein synthesis pathways (Story & 
Lord, 1987). There was a good relationship between the in vitro bile acid binding by 
various fibers and their hypocholesterolemic effect (Vahouny, 1985). 
Dietary fibers increase fecal bile acid excretion by several mechanisms: binding 
of bile acid by forming gels or highly viscous solutions in the intestine, and interfering 
with micelle formation. Pectins and gums may affect bile acid absorption in the small 
intestine through their viscosity and gelling properties, leading to decreased micelle 
formation and entrapment of bile acids and lipids to a greater extent than through their 
physical binding properties (Selvendran, 1987). 
In general, fibers that have significant hypocholesterolemic effects also 
significantly increase fecal bile acid excretion. Fibers that do not have 




1.6.2 Modified Lipid Absorption and Metabolism 
Proposed Mechanisms 
Dietary fibers may affect the absorption of lipids as well as bile acids from the 
small intestine by these and other mechanisms: (1) altered gastric function; (2) decreased 
availability of bile acids; (3) interference with effective micelle formation; (4) altered 
digestive enzyme availability or activity; (5) changes in intestinal mobility and mixing 
of intestinal contents; and (6) alterations in the unstirred water layer or other 
physiological changes in： the absorptive surface. 
1.6.3 Effects of SCFA on Lipid Metabolism 
In the human colon, polysaccharides such as dietary fibers are fermented by a 
rich and difference bacterial population. Short-chain fatty acids (SCFA) including 
acetate，propionate, and butyrate are major end products of this process. Therefore, 
SCFA was proposed to affect hepatic cholesterol metabolism leading to 
hypocholesterolemic effects. In animal studies, increased dietary fiber intakes are 
accompanied by significantly higher portal vein concentration of SCFA than is cellulose. 
In vitro studies using isolated rat liver cells suggest that physiological concentrations of 
propionate may significantly decrease hepatic cholesterol synthesis. Although 
pharmacological doses of propionate and its derivatives inhibit important hepatic lipid 
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regulatory enzymes both in vitro and in vivo, yet effects of physiological doses are not 
well documented. Moreover, some studies concluded that acetate rather than propionate 
was represented for the hypocholesterolemic of effect of dietary fiber. Therefore, this 
mechanism is still under extensive investigation. 
1.6.4 Changed Hormone Concentrations 
Increased intake of dietary fiber affects serum insulin values and levels of several 
other important regulatory hormones, contributing to the regulating of lipid metabolism. 
Insulin is a key regulatory hormone both for lipid synthesis in many body tissues and for 
lipid mobilization from adipose tissue and liver. Glucagon antagonizes many of these 
effects on lipid metabolism. Several studies suggest that serum glucose, insulin and 
glucagons concentration affect rates of hepatic cholesterol and lipoprotein synthesis, 
particularly the secretion of very-low-density lipoprotein. 
High fibers diets compared to conventional diets lower insulin requirement of 
diabetic individuals and decrease serum insulin concentrations of normal subjects. This 
high fiber diets also increase insulin sensitivity of diabetic individuals and normal 
subjects. These reductions in insulin concentration would be expected to reduce hepatic 
cholesterol and fatty acid synthesis. 
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Chapter Two: 
Materials and Methods 
2.1 Materials 
2.1.1 Fungus 
A semi-dried fruiting body of Auricularia polytricha (AP) was purchased in a 
local Chinese medicine store. The Fungus was imported from China. 
2.1.2 Animals 
2.1.2.1 Golden Syrian Hamster 
Male Golden Syrian Hamsters of weight 100 士 lOg were housed in polystyrene 
cage (5 per cage) in a room of 23°C with alternating cycles of 12 h light (7:00 a.m. to 
7:00 p.m.) and 12 h darkness (7:00 p.m. to 7:00 a.m.) in Laboratory Animal Service 
Center (LASC). All hamsters were habituated for one week before the experiments were 
carried out. 
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Fresh semi-synthetic diets were given to hamsters daily and uneaten food was 
discarded. Daily food consumption was recorded and body weight was measured once a 
week. The fecal sample was collected from each cage. All hamsters were allowed to 
access food and water ad libitum. 
2.1.2.2 Rabbit 
Male New Zealand Rabbits of weight � 3 kg were housed in cages (one per cage) 
and living conditions were the same as hamster. Food consumption and body weight 
were recorded and fecal sample was also collected. 
2.1.3 Characterization of Auricularia polytricha 
Dextran 
Dextran was purchased from Sigma Chemical Co., USA with molecular weight 
of 72,200 kD. It was used as a standard for carbohydrate content determination. 
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D-glucurono-6, 3-lactone 
D-glucurono-6, 3-lactone was purchased from Aldrich Chem. Co., USA. It was 
used as a standard for uronic acid content determination. 
Sodium tetraborate-lO-hydrate 
Sodium tetraborate-10-hydrate was purchased from Riedel-deHaen, Germany. 
Nine hundred milligrams of sodium tetraborate decahydate was dissolved in 10 ml of 
叫 0 and 90 ml of ice-cold 98% concentrated sulfuric acid was added carefully to form 
a layer. It was allowed to leave undisturbed overnight to mix without excessive heat 
production. The mixture (Reagent A for Carbazole assay for uronic acids determination) 
was checked to ensure that it was thoroughly mixed and at room temperature before use. 
This reagent was stable indefinitely if refrigerated. 
Carbazole 
Carbazole was purchased from Aldrich Chem. Co., USA. One hundred 
milligrams of carbazole was dissolved in 100 ml absolute ethanol and it was Reagent B 
for Carbazole assay for uronic acids determination. This reagent was stable indefinitely 
if refrigerated. 
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Bovine Serum Albumin (BSA) 
BSA was purchased from Sigma Chemical Co., USA. It was used as a standard 
for BCA protein assay. 
Bicinchoninic acid solution (Reagent A) 
Bicinchoninic acid solution was purchased from Sigma Chemical Co., USA. It 
was one of the reagents used for the BCA protein Assay. 
Cupric sulphate (Reagent B) 
Cupric sulphate was purchased from BDH Chemicals Ltd., England. Two grams 
of cupric sulphate was dissolved in 50 ml of d H ? � . It was one of the reagents used in the 
BCA protein Assay. 
a-Naphthol 
a-Naphthol was purchased from Sigma Chemical Co., USA. It was used as a 
component for the visualizing reagent of thin layer chromatography. 
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Sodium bisulfite 
Sodium bisulfite was purchased form Sigma Chemical Co., USA. It was used to 
pretreat the TLC plate prior to spotting. 
Blue dextran 
Blue dextran was purchased from Sigma Chemical Co., USA with average 
molecular weight larger than 200 kD. It was used for the estimation of molecular weight 
of AP Polysaccharide. 
Monosaccharide standards 
A set of monosaccharide standards including mannose, glucosamine, talose, 
galactosamine, glucose, galactose, xylose, and fucose were all purchased from Sigma 
Chemical Co., USA. 
Trifluoroacetic acid (TFA) 
TFA was purchased from Sigma Chemical Co., USA. It was used in the 
hydrolysis of polysaccharide prior to HPLC analysis. 
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3-Methyl-l-phenyl-2-pyrazolin-5-one (PMP) 
PMP was purchased from Aldrich, USA. PMP can react with reducing 
carbohydrates almost quantitatively to yield 2:1 compounds having no stereoisomers, 
which strongly absorb UV light at 245 run. PMP must be recrystallized from methanol 
before use. 
Butyl ether 
Butyl ether (GC) was purchased from Fluka Chemie GmbH, Germany and acted 
as an extraction solvent in High Performance Liquid Chromatography (HPLC) analysis 
of monosaccharides. 
2.1.4 Chromatographic materials 
Sepharose CL-4B 
The gel was purchased from Pharmacia LKB, Sweden and used to fractionate AP 
Polysaccharide. Sepharose CL-4B has a fractionation range of molecular weight of 30-
5000K. 
22 
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Materials and Methods 
TLC plate 
The glass plates are pre-coated with Kiesegel 60 F254 of dimensions of 20cm x 
20cm. The plates were purchased from E. Merck, Germany. 
C-18 HPLC column 
The RP-HPLC column was purchased from Rainin LC & Supplies, USA. C-18 
column was used for the separation of monosaccharides from hydrolysate of 
polysaccharide with particle size of 5 [im and pore size of 100 A. The dimension of the 
column is 4.6 x 250.0 mm. 
AG® 1-X8 formate resin 
AG® 1-X8 formate resin was purchase from Bio Rad, CA and was an anion 
exchange resin. In the HMG-CoA Reductase assay, the product mevalonolactone formed 
was retained by this resin. 
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Silica Capillary GC Column 
A fused silica capillary column (SAC™-5, 30 m x 0.25 mm, i.d.) was purchased 
from Supelco, Inc., Bellefonte, PA. It was used for GLC analysis of TMS-ether 
derivative of cholesterol, neutral sterols and acidic sterols. 
HPLC System 
AKTA Purifier: P-900, UV-900, pH/C-900, INV-907, PV-908, M-925 & Frac-
900, Amersham Pharmacia Biotech 
2.1.5 Determination of Plasma TC, HDL-C, LDL-C, TG, AST and ALT 
Plasma Total Cholesterol (TC) 
Plasma TC level was determined by using Sigma Diagnostic Total Cholesterol 
Kit purchased from Sigma Chemical Co., St. Louis, MO, USA. 
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High Density Lipoprotein Cholesterol (HDL-C) 
Plasma HDL-C was determined by using a HDL cholesterol reagent purchased 
from Sigma Chemical Co., St. Louis, MO, USA. 
Low Density Lipoprotein Cholesterol (LDL-C) 
Plasma LDL-C was determined by using Sigma Diagnostics LDL Cholesterol 
Kit purchased from Sigma Chemical Co., St. Louis, MO, USA. 
Triglyceride (TG) 
Plasma TG was determined by using Sigma Diagnostic Triglyceride Kit 
purchased from Sigma Chemical Co., St. Louis, MO, USA. 
Aspartate Aminotransferase (AST) 
Plasma AST was determined by using Sigma Diagnostic AST Kit purchased 
from Sigma Chemical Co., St. Louis, MO, USA. 
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Alanine Aminotransferase (ALT) 
Plasma ALT was determined by using Sigma Diagnostic ALT Kit purchased 
from Sigma Chemical Co., St. Louis, MO, USA. 
2.1.6 HMG-CoA Reductase Activity Assay 
Homogenizing Buffer 
Homogenizing buffer contains 0.1 M sucrose, 0.05 M KCl, 0.03 M EDTA and 
0.04 M KH2PO4 at pH 7.2. 
Assay Buffer 
Assay buffer contains 0.06 M EDTA, 37.8 mM NaCl, 0.14 M sucrose, 0.07 M 
KCl and 0.056 M KH2PO4 at pH 7.2. 
Dithiothreitol (DTT) (purchased from Sigma Chemical Co., USA) 
Glucose-6-Phosphate Dehydrogenase (G6PDH) (purchased from Sigma Chemical Co., 
USA) 
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Glucose-6-Phosphate (G6P) (purchased from Sigma Chemical Co., USA) 
Nicotinamide Adenine Dinucleotide Phosphate (NADP) (purchased from Sigma 
Chemical Co., USA) 
HMG-CoA, DL-3-[glutaryl-3-''C]- (purchased from NEN™ Life Science Products, 
Inc., MA) 
Mevalonolactone, RS-[5-3H(N)]- (purchased from NEN™ Life Science Products, Inc., 
MA) 
Scintillation Fluid, (OptiPhase "HiSafe" 3 universal scintillation cocktail) 
2.1.7 Quantitative Determination of Liver Cholesterol, Acidic and 
Neutral Sterol 
Stigmastanol 
Stigmastanol was purchased from Sigma Chemical Co., USA and used as an 
internal standard for liver cholesterol determination. 
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Hyodeoxycholic acid 
Hyodeoxycholic acid was purchased from Sigma Chemical Co., USA and used 
as an internal standard for acidic sterol determination. 
Stigmasterol 
Stigmasterol was purchased from Sigma Chemical Co., USA and used as an 
internal standard for neutral sterol determination. 
Sil-A reagent 
Sil-A reagent is a commercial TMS-reagent which was purchased from Sigma 
Chemical Co.，USA. Sil-A was used for the conversion of cholesterol in the samples into 
its trimethylsilyl (TMS)-ether derivative. 
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2.1.8 Animal Diets 
2.1.8.1 Hamster Diets 
All the semi-synthetic diets were based on a high cholesterol diet with 0.1% of 
pure cholesterol added except for normal diet. The ingredients included casein, lard, 
starch, sucrose, mineral mix, vitamin mix, DL-methionine and cholesterol. With 2% of 
AP Polysaccharide added, 1% of starch and 1% of sucrose were subtracted from the 
ingredients. For the short chain fatty acid (SCFA) test group, 0.5% of starch and 0.5% of 
sucrose were replaced with 1% of each SCFA. The composition of diets are shown in 
Table 2.1. 
2.1.8.2 Rabbit Diets 
All diets were purchased by Glen Forrest Stockfeeders, West Australia. The 
normal diet was based on the formula provided by Glen Forrest Stockfeeder. The details 
of diet preparation were as follow. Two tons of a commercial diet formulated for rabbits 
was prepared according to the company's standard operating procedures and 
specifications. One ton of the diet was returned to the mixing chamber before pelleting 
and 20 kg of cholesterol (1%) (grade: NF (USP), purity: >95% (GLC)) added and it was 
the control diet. The other ton of diet was pelleted and formed the normal diet without 
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cholesterol as shown in Table 2.2. The normal pelleting process involve steam injection 
and heating to 85°C for 10 to 20 minutes. To minimize storage changes both the control 
and cholesterol diets were stored at 4°C. Because of shortage of APP, the test diet 
preparation was scaled down with supplementation of 1% cholesterol and with 2% APP 
added; other conditions remain unchanged. 
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Table 2.1. Composition of Experimental Diets for Hamsters 
Content (% w/w) 
Ingredients Control Test Ac Pr Bu Ac,Pr 
Casein ^ ^ i K o ^ 
Lard 20.0 20.0 20.0 20.0 20.0 20.0 
Starch 42.8 41.8 42.3 42.3 42.3 42.3 
Sucrose 11.0 10.0 10.5 10.5 10.5 10.5 
Mineral Mix 4.0 4.0 4.0 4.0 4.0 4.0 
Vitamin Mix 2.0 2.0 2.0 2.0 2.0 2.0 
DL-Methionine 0.1 0.1 0.1 0.1 0.1 0.1 
Cholesterol 0.1 0.1 0.1 0.1 0.1 0.1 
AP Polysaccharide / 2.0 / / / / 
Sodium Acetate / / 1.0 / / 0.5 
Sodium Propionate / I I 1.0 / 0.5 
Sodium Butyrate / / / / 1.0 / 
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Table 2.1. Composition of Normal Diet for Rabbits 
Ingredients Content (% w/w) 
Oats 5 m 
Lupins 20.50 
Millmix 25.00 
Meat Meal 1.70 
Lucerne 32.00 
Wheaten Chaff 16.00 
Dicalcium phosphate 0.57 
Tallow 0.50 
Fish oil 0.50 
Vegetable oil 3.80 
Vitamin and Mineral premix 0.49 
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2.2 Methods 
2.2.1 Extraction of Water-Soluble AP Polysaccharide (APP) 
Fungus Auricularia polytricha was dried in an oven at 50°C overnight to remove 
residual water. Two hundred grams of dried fungus were broken down into small pieces 
and boiled in 3 liters of hot water (80°C) for 8 hours (Kiho et al, 1991). The water 
extraction was subjected to centrifugation (18,480 g, 30 min.) to remove small particles. 
The extract was then subjected to lyophilization for 5 days and finally dried water-
soluble crude AP polysaccharide was obtained. 
Crude AP polysaccharide can be semi-purified by ethanol precipitation. One 
gram of crude AP polysaccharide was first dissolved in 20 ml of dHsO. The precipitated 
polysaccharide (APP-A) was obtained by adding 30 ml of absolute ethanol (1:1.5 v/v) 
after centrifugation. The remaining solution was pooled together and further 30 ml of 
absolute ethanol was added and precipitated polysaccharide (APP-B) was obtained (1:3 
v/v) after centrifugation. 
33 
I 
Materials and Methods 
2.2.2 Characterization of Auricularia polytricha 
2.2.2.1 Determination of carbohydrate content of AP Polysaccharide 
The method of (Dubois M. et al, 1956) was adopted. In the assay, dextran (MW 
72,200) was used as a standard. Phenol reagent (200 jal, 5%) was mixed with 200 
sample (1 mg/ml dHaO). To the 400 pi mixture, 1 ml concentrated sulfuric acid was 
added and allowed to stand for 30 min at room temperature. The absorbance of the 
reaction mixture at 490 nm was then measured. The amount of carbohydrate present was 
calculated from the dextran standard curve. 
2.2.2.2 Determination of uronic acid content of AP Polysaccharide 
The method of (Taylor & Buchanan-Smith，1992) was adopted. In the assay, 
samples, standards, and controls (250 \il) were cooled in an ice-bath. 1.5 ml ice-cold 
Reagent A (see section 2.1.2) was added carefully with mixing and cooling in the ice-
bath. The mixture was heated at 100°C for 10 min and then was cooled rapidly in an ice-
bath. 50 1^1 of Reagent B (see section 2.1.2) was added and mixed well. The mixture was 
reheated at 100°C for 15 min and then cooled rapidly to room temperature. The 
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absorbance of the reaction mixture at 525 nm was then measured. The amount of uronic 
acids present was calculated from the D-glucurono-6, 3-lactone standard curve. 
2.2.2.3 Determination of protein content of AP Polysaccharide by BCA 
protein assay 
The protein assay reagent was prepared by adding 9.8 ml of reagent A to 200 
of reagent B (see section 2.1.2). 2 i^l and 4 of 5 mg/ml of samples were added to 96-
well plate and 200 [xl of protein assay reagent was added to each well. The plate was 
incubated for 30 min and absorbance at 540 nm was measured. The average protein 
content of the samples was calculated from the BSA standard curve (Walker, 1994). 
2.2.2.4 Determination of component sugar units of AP Polysaccharide 
The method of (Szustkiewicz & Demetriou，1971) was adopted for 
chromatographic separation of monosaccharide units from hydrolyzed samples. 
Hydrolysis was done by adding 5 mg of polysaccharide or standards (Glucose, Mannose, 
Xylose, Galactose, Fucose, Arabinose) were dissolved in 0.25 ml of 2M HCl and heated 
at 100°C for periods of 3 hr in a sealed tube. The TLC plate was pretreated by 
impregnating the layer with 0.1 M sodium bisulfite. The plate was air-dried and 
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activated it at 100°C for 30 min prior to spotting. The hydrolysate (2 jul) from each 
sample was spotted on a TLC plate (Kiesegel 60 F254, Merck). The spots were air-dried, 
and the TLC plate was developed in a fume hood for a distance of 10 cm in a tank 
saturated with mobile phase, ethylacetate: formic acid: acetic acid: dH20 (10:1:3:2). The 
plate was then removed and air-dried. The monosaccharides on the TLC plate were 
detected by a-Naphthol-SulfUric acid visualizing reagent rather than alkaline silver 
staining method (Trevelyan W.E. et al, 1950). The visualizing reagent was prepared by 
adding 5 g of a-Naphthol to 33 ml ethanol, then 13 ml H2SO4, 81 ml ethanol and 8 ml 
H2O. The TLC plate was sprayed with this visualizing reagent and heated for 5 min at 
100�C. 
2.2.2.5 Fractionation of AP Polysaccharide 
Gel filtration chromatography (Andrews P., 1965) was used to fractionate AP 
Polysaccharide. Sepharose CL-4B gel was pre-swollen when it was purchased. 
Sepharose gel was packed in a column of 2.6 cm x 60 cm dimension. The gel was eluted 
with 0.1 M NaCl (running buffer) for equilibration. Twenty milligrams per milliliter of 
AP Polysaccharide was dissolved in 0.1 M NaCl and 1 ml of sample solution was 
applied to the column. The flow rate of the packed column was adjusted to 0.25 ml/min 
with a peristaltic pump. The eluent of the column was collected by a fraction collector 
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(FRAC-200, Pharmacia Biotech., Sweden) with each tube collected 3 ml eluent. The 
void volume of the column was characterized by Dextran (Average MW > SOOOkD, 10 
mg/ml). The detection of samples and dextran were determined by phenol-sulfuric acid 
assay at 490 nm. 
2.2.2.6 Determination of monosaccharides of AP Polysaccharide by HPLC 
Hydrolysis 
Samples of polysaccharide (50 |ag) were dissolved in 1 ml of 6 M trifluoroacetic 
acid (TFA) (Kwon & Kim, 1993) in a hydrolysis tube (13 x 100mm) fitted with a 
Teflon-lined screw cap. Talose (2 nmol) as an internal standard was added to each 
sample. The hydrolysis tube was sealed and incubated at 121�C for 2 h in a heating 
block. A set of monosaccharide standards, 10 nmol each of mannose (Man), 
glucosamine (GlcN), talose (Tal), galactosamine (GalN), glucose (Glc), galactose (Gal), 
xylose (Xyl), and flicose (Fuc), was treated identically as the samples. After being 
cooled to room temperature, the hydrolysis tubes were opened, and—each reaction 
mixture was transferred to a microcentrifuge tube and then evaporated to dryness by 
concentration under reduced pressure. The residue was then dissolved in 0.5 ml of 2-
propanol and again evaporated to dryness to remove residual TFA (Honda et al, 1989). 
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Re-crystallization of PMP 
100 ml of methanol was added to 50 g of PMP. The solution was mixed by 
shaking on an orbital mixer at 40-50°C for 5-6 min. An homogeneous yellow solution 
was formed and allowed to cool at room temperature for 1-2 hr. White PMP crystals will 
settle at the bottom while a yellow solution remains at the top. The yellow solution was 
decanted and the crystal was briefly rinsed with methanol. The crystal was dried in 
desiccators or oven for 1-3 hr, 0.5 M PMP solution was prepared to check purity (Fu & 
O'Neill, 1995). The absorbance must not grater than 0.025AU at 400 nm, otherwise, a 
second re-crystallization should be performed. 
PMP Labeling 
The dried hydrolyzed polysaccharide sample and monosaccharide standards were 
directly labeled with PMP (Fu & O'Neill，1995)by adding 20 of PMP solution (0.5 M 
in methanol) and 20 of sodium hydroxide solution (0.3M)，vortexing, and incubating 
at 70�C for 2 h (White et al, 1979). The mixture was then neutralized by vortexing for at 
least 5 s. Phase separations were enhanced by brief centrifugation. The organic phase 
(upper layer) was carefully removed and discarded. This extraction process was repeated 
two more times. The resulting aqueous phase was mixed with water (150 \i\) and 
subjected to centrifugation to remove particles prior to HPLC analysis. 
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HPLC Analysis 
Analysis of the PMP-labeled monosaccharides was carried out on by a HPLC 
system (AKTA Purifier) provided by Amersham Pharmacia Biotech. A C-18 column, 
220 X 2.1 mm, (Rainin LC & Supplies，USA) for the separation of PMP-labeled 
carbohydrates, was used. The flow rate was set to 200 jal/min. The wavelength for UV 
detection was 245 nm. For neutral and amino sugar separation, buffers A and B were 
lOOmM ammonium acetate (pH 5.5) with 10 and 40% acetonitrile, respectively. A 
gradient of 20% to 75% buffer B in 90 min was used for separation. 
2.2.3 Determination of plasma TC, HDL-C, LDL-C, TG, AST and ALT 
2.2.3.1 Plasma Total Cholesterol 
The Diagnostic Kit involves enzymatic reactions in measuring TC content. 
Cholesterol esters are first hydrolyzed by cholesterol esterase (EC 3.1.1.13) to 
cholesterol. The cholesterol produced by hydrolysis is oxidized by cholesterol oxidase 
(EC 1.1.3.6) to cholest-4-en-3-one and hydrogen peroxide (H2O2). The hydrogen 
peroxide produced is then coupled with the chromogen, 4-aminoantipyrine and p_ 
hydroxybenzenesulfonate in the presence of peroxidase (EC 1.11.1.7) to yield a 
quinoneimine dye which has an absorbance maximum of 500 nm. The intensity of the 
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color produced is directly proportional to the total cholesterol concentration in the 
plasma sample. 
2.2.3.2 Plasma HDL-Cholesterol 
The HDL cholesterol reagent contains phosphotungstic acid in MgCl� � 
precipitates LDL and VLDL fractions of the plasma, leaving the HDL fraction in 
solution. Cholesterol concentration in HDL fraction was then assayed by the enzymatic 
kit that is used in measuring plasma total cholesterol. 
2.2.3.3 Plasma LDL-Cholesterol 
The LDL cholesterol reagent utilizes latex beads coated with affinity purified 
goat polyclonal antisera to specific human apolipoproteins which facilitate the removal 
of HDL and VLDL in the specimen. After a short incubation and centrifUgation，the 
LDL cholesterol remains in the filtrate solution. The LDL cholesterol concentration was 
determined by the enzymatic kit that is used in measuring plasma total cholesterol. 
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2.2.3.4 Plasma Triglyceride 
Methods for triglycerides determination generally involve enzymatic hydrolysis 
or alkaline hydrolysis of triglycerides to glycerol and free fatty acid following by either 
chemical or enzymatic measurement of the glycerol released. Enzymatic hydrolysis 
following by enzymatic measurement was employed by this Triglyceride Diagnostic Kit. 
Triglycerols were hydrolyzed by lipase to glycerol and free fatty acid. The 
glycerol produced was then measured by coupled enzyme reactions catalyzed by 
glycerol kinase, glycerol-1-phosphate dehydrogenase and diaphorase. 
2.2.3.5 Plasma Aspartate Aminotransferase 
AST catalyzes the transfer of the amino group from aspartate to 2-oxoglytarte to 
yield oxalacetate and glutamate. The oxalacetate was reduced to malate in the presence 
of malate dehydrogenase with the simultaneous oxidation of reduced nicotinamide 
adenine dinucleotide. The rate of decrease in absorbance at 340 nm was directly 
proportional to AST activity. -
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2.2.3.6 Plasma Alanine Aminotransferase 
ALT catalyzes the transfer of the amino group from Alanine to 2-oxoglutarate, to 
form glutamate and pyruvate. The pyruvate formed was then reduced to lactate in the 
presence of lactate dehydrogenase with simultaneous oxidation of reduced nicotinamide 
adenine dinucleotide. The rate of decrease in absorbance at 340 nm was directly 
proportional to ALT activity. 
2.2.4 HMG-CoA Reductase Activity Assay 
2.2.4.1 Preparation of Hepatic Microsome 
2 g of liver sample was homogenized in 3 volumes of homogenizing buffer using 
a glass Potter-Elvehjem homogenizer with Telfon pestle (Dietschy & Spady，1984). The 
homogenate was centrifiiged at 12,000 g for 10 min at 4 � C . Fat layer was removed by 
filtering through a piece of muslin. The filtrate was then centrifiiged again at 105,000 g 
for 60 min. The pellet obtained after centrifugation was resuspended in 1 ml 
homogenizing buffer and the protein content was determined by BCA protein assay. The 
microsome was stored at —70°C before use if not use immediately. 
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2.2.4.2 HMG-CoA Activity Assay 
For each assay, 150 [x\ microsome preparation was mixed with 100 assay 
buffer (pH 7.2), 10 |LI1 54 mM dithiothreitol (DTT), 10 jal G6PDH (40 units/ml), 10 jiil 
G6P (162 mM), 10 i^l NADP (16.2 mM) and 30 )il dH^O (Vergara-Jimenez et al, 1998). 
The mixture was pre-incubated at 37�C for 20 min with shaking. The reaction mixture 
was initiated by adding 10 |LI1 of HMG-CoA, DL-3-[glutaryl-3-^^C]- with 1 Ci/mol. The 
reaction mixture was then further incubated at 37°C for 60 min. After incubation, the 
reaction was stopped by adding 25 of 5 N HCl and 10 i^l of mevalonolactone, RS-[5-
^H(N)]- with 10 |LiCi/ml was added as internal standard. The total reaction mixture was 
then incubated at 37°C for 30 min. After incubation, the precipitated protein was 
removed by brief centrifugation and 200 [x\ of supernatant was applied to an AG® 1-X8 
formate (Edwards et al, 1979) column (0.7 x 10 cm, purchased from Bio-Rad, CA), 
made up in water. The column was then eluted with H2O, the first 300 jil was discarded 
and the next 3 ml fraction was collected. The collected eluent was mixed with 19 ml 
liquid scintillation fluid fon scintillation counting. Time zero assay, no substrate assay 
and no microsome protein background were also performed which was needed for the 
calculation of the HMG-CoA Reductase activity. One unit of HMG-CoA Reductase 
activity was defined as one pmol/min/mg protein. 
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2.2.5 Quantitative Determination of Liver Cholesterol 
2.2.5.1 Cholesterol Extraction and its Silylation 
Three hundred milligrams of liver were weighed and one milligram of 
stigmastanol (dissolved in chloroform-methanol (2:1, v/v)) was added as an internal 
standard. The liver was then homogenized in 15 ml chloroform-methanol (2:1，v/v) and 
3 ml saline using a Polytron homogenizer. Phase separation was enhanced by 
centrifugation at 3,000 ipm for 15 min using a table-top centrifuge. After centrifugation, 
the bottom organic layer was collected and dried by nitrogen gas. The samples were then 
subjected to alkaline hydrolysis with 5 ml 1 N NaOH in 90% ethanol at 90°C for 1 hour. 
Six milliliters of cyclohexane and 1 ml of dH20 were added for cholesterol extraction. 
Phase separation was enhanced by brief centrifugation. The upper cyclohexane layer 
was collected and evaporated under nitrogen gas. Three hundred milliliters of TMS-
reagent (dry pyridine-hexamethyldisilazane-tricholrosilane, 9:3:1，v/v/v, Sil-A reagent, 
Sigma Chemical Co., USA) was added for the conversion of sample cholesterol to its 
trimethylsilyl (TMS)-ether derivative. It was then incubated at 6 0 � C for 1 h •and the 
mixture was dried under nitrogen gas. The derivative was dissolved in 600 \i\ of hexane 
and the hexane was transferred to a GC vial for GLC analysis after centrifugation. 
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2.2.5.2 GLC Analysis of TMS-Ether Derivative of Cholesterol 
The TMS-ether derivative was analyzed on a fused silica capillary column in a 
Shimadzu GC-14B gas-liquid chromatograph equipped with a Shimadzu flame-
ionization detector. Column temperature was programmed at 285°C and maintained for 
20 min. Helium was used as the carrier gas at a head pressure of 22 psi. 
2.2.6 Quantitative Determination of Neutral and Acidic Sterols 
2.2.6.1 Separation of Neutral and Acidic Sterols 
Three hundred milligrams of fecal samples were dried by lyophilization and then 
ground to powder form. One milliliter of 0.3 mg/ml stigmasterol in chloroform and one 
milliliter of 0.3 mg/ml hyodeoxycholic acid in 1 N NaOH were added to the fecal 
sample as internal standards for neutral and acidic sterols respectively. Alkaline 
hydrolysis of samples was carried out by adding 8 ml 1 N NaOH in 90% ethanol at 90°C 
for 1 h. The sample mixture was then cooled down to room temperature. Extraction was 
performed by adding 1 ml of (！即 and 8 ml of cyclohexane. After centrifligation, the 
lower aqueous layer and the upper organic layer (cyclohexane) were collected for acidic 
and neutral sterols analysis respectively. 
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2.2.6.2 Conversion of Neutral Sterols to its TMS-Ether Derivative 
The cyclohexane layer was evaporated to dryness under nitrogen gas. Three 
hundred milliliters of TMS-reagent (Sil-A) was added and heated at 60�C for 1 h for the 
conversion of neutral sterols into its TMS-ether derivatives. The mixture was then 
evaporated to dryness under nitrogen gas and the resulting pellet was dissolved in 400 i^l 
of hexane. After centrifugation, the hexane layer was transferred to a GC vial for GLC 
analysis. 
2.2.6.3 Conversion of Acidic Sterols to its TMS-Ether Derivatives 
The remaining aqueous phase was left for acidic sterols analysis. One ml of ION 
NaOH was added to the aqueous phase and the mixture was heated at 120�C for 3 h. The 
tube was then cooled to room temperature. One ml of d H � � a n d 3 ml 25% HCl (pH<l) 
were added for acidification. The mixture was extracted with 7 ml of diethyl ether twice. 
Phas—e separation was enhanced by brief centrifiigation. The ether phase was then dried 
down by nitrogen gas. Methylation was performed by adding 2 ml methanol, 2 ml 
dimethoxypropane and 40 concentrated HCl. The mixture was vortexed thoroughly 
and allowed to stand overnight at room temperature. The solvent was dried down by 
nitrogen gas and 300 i^l TMS-reagent (Sil-A) was added for conversion of acidic sterols 
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into its TMS-ether derivatives. The mixture was then dried down by nitrogen gas and the 
resulting residue was dissolved in 300 i^l hexane. After centrifligation, the hexane layer 
was transferred to a GC vial for GLC analysis. 
2.2.6.4 GLC Analysis of Neutral and Acidic Sterols 
The GLC analysis of fecal neutral and acidic sterols was performed by a fused 
silica capillary column as described in section 2.2.5.2. For neutral sterols, the column 
temperature was programmed at 285°C and maintained for 30 min. For acidic sterols, 
the column temperature was programmed at 230''C to 280°C at a rate of l�C/min. 
Helium was used as the carrier gas at a head pressure of 22 psi in both neutral and acidic 
sterol GLC. 
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2.2.7 Study of Atherosclerosis of Rabbit 
2.2.7.1 Sudan III staining of the thoracic aorta 
At the end of the week rabbits were bled and weighed before being 
sacrificed by CO:. The rabbits were opened using a mid-line incision from the pubis to 
the xiphoid process, exposing the abdominal viscera. The rib cage was removed by 
cutting the ribs down both sides of the thorax, exposing the thoracic viscera. Whilst 
livers from the rabbits were harvested for cholesterol determination, for the study of 
atherosclerosis, the thoracic aorta from the bulb of the aorta to the branching of the 
celiac artery was removed (Popesko et al, 1992). 
The fresh aortas were obtained and cleaned of all visible adventitial tissue and 
washed in saline solution until all traces of blood had been removed. The vessels were 
cut longitudinally and immersed in a solution of Sudan III (4 g in 70% alcohol) (Haines 
et al, 1999) for 45 min to identify atheromatous lesions on the surface of the aorta. This 
is an established method of staining vessels to identify atheroma formation (Holma et al, 
1958; Wilson et al, 1982; Smith & Burton，1977). Sudan III is an organotrophic dye 
which was previously thought to stain lipid on the principle that the dye was more 
soluble in tissue fat than the dye solvents. However, it is considered that the staining of 
lipids is due to adsorption of the dye by the lipid. Following preparation and staining, the 
thoracic aorta was pinned to a corkboard with the intimal surface face down in order to 
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remove any residual adventitial fat shown up by staining. The features of the intimal 
surface were then captured by digital scanning and stored as a bitmap using established 
methodology (Haines et al, 1999). 
2.2.7.2 Measurement of atheroma formation in the aorta 
Atheroma on the intimal surface of the aorta was identified using a self-
organizing map neural network to characterize tissue according to selective color 
staining. A self-organizing map neural network clusters input patterns from the scanned 
image to a given software output node. The map is initially trained by presented 
normalized input patterns, in this case the individual color components of each pixel 
from a test image, to the neural network. Internally the network compares the input 
pattern to one of its pre-existing patterns associated with each output to see which it is 
closest to. The difference between the input pattern and the best matching pattern 
represents the training error. The input patterns are presented repetitively until all input 
patterns can be matched to all available outputs, to a predefined error level. At this point 
the network is trained and available to interpret other images of a similar type, in this 
case the scanned images of the Sudan III stained aortas. The matching patterns initially 
are set to randomized values and hence the final matching patterns used to interpret 
other images are empirically derived. This ability to interpret the color pattern of the 
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scanned images allows the computer program to calculate the area of aortic atheroma 
and the area of normal aorta. The area of atheroma was expressed as a percentage of the 
total area of aorta scanned into the computer. 
The percentage was calculated as follows: 
Total area of atheromatous plaques (i.e. area stained with Sudan III) ^ ^ qq 
Total area of atheromatous plaques + Total area of normal intima 
(i.e. area stained with Sudan III + area not stained) 
The images were captured as 24 bit true color using a Hewlett Packard Scanjet 
6100C desk scanner. All images were captured at a horizontal and vertical resolution of 
300 dpi (a pixel to pixel distance of 0.085mm) using a brightness setting of 126 units 
and a contrast of 112 units. Prior to image capture all specimens were placed adventitial 
side down on to white tissue and then turned over with the intimal surface placed onto a 
layer of saline solution on the glass surface of the scanner. The saline solution acted as a 
transmission medium between the glass surface of the scanner and the tissue, thereby -
minimizing surface reflections. This method is a simple and reliable method of image 
quantification according to the degree of stain absorption using a self-organizing map. It 
was successfully used in this study to identify atheromatous plaques of different sizes 
and shapes on the surface of the aorta. Patterns with broadly similar shades can be 
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reduced to one or more generic patterns aiding plaque identification and measurement. 
All images obtained for analysis in this study were captured using the same scanner with 
fixed contrast and brightness settings. This was done so as to exclude any difference due 
to different lighting sources employed by individual manufacturers within their products. 
The neural map offers the advantages that it is consistent and repeatable. 
2.2.8 Animal Experiments 
2.2.8.1 Protective Effect of APP in Hyperlipidemic Study (Exp. 1) 
Twenty hamsters (100 士 5 g) were habituated and fed with commercial diet for 
one week. The hamsters were then divided randomly into two groups (n=10 per group) 
and fed with different experimental diet for four weeks. The experimental diets were 
composed of a semi-synthetic and high-cholesterol diet, with supplementation of 2% 
APP. The semi-synthetic diets were prepared with the method described by Sanders & 
Sandaradura (Trowell et al, 1976) with little modification. The control group was fed 
with control diet and test group was fed with AP diet (Table 2.1). The powder diet was 
then mixed with gelatin solution (20 g/L). The diet was made into small pieces and 
stored at -20°C. 
At the end of week 4, all hamsters were fasted for at least 16 h before they were 
sacrificed. Blood was collected in a heparin tube via the abdominal aorta and centrifuged 
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at l,500g for 10 min. The livers were washed with saline and weighed after 
exsanguinations. Liver was frozen in liquid nitrogen and stored in -70°C for cholesterol 
analysis. 
2.2.8.2 Therapeutic Effect of APP in Hyperlipidemic Study (Exp. 2) 
Twenty hamsters (100 ± 5 g) were fed with control diet for 4 weeks in order to 
boost the hamsters into hyperlipidemic state(Talwinder et al, 1997). After 4 weeks, all 
hamsters were divided into two groups randomly (n=10 per group). Control group was 
fed with control diet and test group was fed with AP diet (Table 2.1). 
Four weeks later (week 8)，five hamsters from each group were sacrificed after 
overnight fasting. Blood and liver were collected as described in section 2.2.8.1. Four 
weeks later (week 12), the remaining hamsters were sacrificed and treated as previously. 
The parameters measured were the same as experiment 1. 
2.2.8.3 Dose Response of APP in Hyperlipidemic Study (Exp. 3) 
Forty hamsters (100 ± 5 g) were divided into four groups randomly (n=10 per 
group) and fed with different experimental diets diet for 4 weeks. The experimental diets 
Materials and Methods 
were composed of a semi-synthetic and high-cholesterol diet, with supplementation of 
1%, 2% and 4% APP. 
At the end of week 4，all hamsters were sacrificed after overnight fasting and 
same analysis was performed as previously. 
2.2.8.4 Hypolipidemic Effect of Short Chain Fatty Acid (Exp. 4) 
Sixty hamsters (100 ± 5 g) were divided into six groups randomly (n=10 per 
group) and fed with different experimental diets for 4 weeks. The experimental diets 
were composed of a semi-synthetic and high-cholesterol diet, with supplementation of 
lo/o sodium acetate, sodium propionate sodium butyrate and APP (Chen et al, 1984). 
One group fed with supplementation of 0.5% sodium acetate and 0.5% propionate. 
(Table 2.1) 
At the end of week 4，all hamsters were sacrificed after overnight fasting and 
same analysis was performed as previously. 
2.2.8.5 Effect of APP and SCFA on HMG-CoA Reductase Activity (Exp. 5) 
All sixty hamsters were treated identically as described in section 2.2.8.4 except 
-without overnight fasting. Only livers were collected for measuring HMG-CoA 
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Reductase activity. Liver microsome fractions were obtained immediately and not stored 
(-70°C) more than one 24 hr to prevent enzyme degradation. All fractions were tested at 
once without repeating freeze and thaw. 
2.2.8.6 Hypolipidemic and Anti-atherosclerotic Effect of APP (Exp. 6) 
Twelve New Zealand rabbits were divided into three groups randomly (n=4 per 
group) and fed with different experimental diets for 12 weeks. The experimental diets 
were composed of a normal diet, with supplementation of 1% cholesterol (control group) 
or 1% cholesterol & 2o/o APP (test group). The third group was fed with a normal diet 
without cholesterol. The same analysis was performed as previously plus the 
measurement of atheroma formation in the aorta. 
2.3 Statistical analysis 
All results were expressed as the arithmetic mean 土 standard derivation (S.D.). 
Student's "t" test was used to determine the confidence limits in population comparisons. 
P < 0.05 was regarded as significant. 
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Chapter Three: 
Fractionation and Characterization of 
Auricularia polytricha Polysaccharide (APP) 
3.1 Introduction 
The role of dietary fiber (DF) in human nutrition and health has become 
increasingly topical in recent years as its physiological effects have been more widely 
appreciate and as its chemistry has been better understood. Polysaccharides, which are 
the principal constituents of dietary fiber, show a wide spectrum of physical properties, 
reflecting the nature and extent of intermolecular association. At one extreme, the 
polymer chains may be packed together into ordered assemblies, such as cellulose fibrils, 
which are almost totally resistant to hydration and swelling. At the other extreme, 
- polysaccharide chains can exist in solution as fluctuating, disordered coils, interacting 
with one another only by physical entanglement. Between these extremes lie on the 
hydrated, swollen networks typical of plant tissue and of many manufactured foods. 
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Trowell et al. (1976) (Trowell et al, 1976) defined DF as all the polysaccharides 
and lignin in the diet that are not digested by the endogenous secretions of the human 
digestive tract. For analytical purposes, DF refers mainly to the non-starch 
polysaccharides and lignin we consume (Southgate, 1976). However, lignin is not 
polysaccharide and only non-starch polysaccharide is defined as DF. 
3.2 Fungal polysaccharides from Auricularia polytricha 
All flingal walls contain a mixture of fibrillar components and amorphous or 
matrix components (PCK Cheung, 1997). In Basidiomycetes, the main fibrillar 
components include chitin which is a straight-chain b-(l-4)-linked polymer of N_ 
acetylglucosamine and the main matrix components include various polysaccharides 
(such as a- and b-1-3 glucans, and mannans), proteins, and small amounts of lipids. 
Therefore, most of the edible fungi (mainly from the Basidiomycetes) are rich in 
nonstarch polysaccharides which can be a good source of dietary fiber for humans 
Auricularia, a group of jelly fungi, are-X)ften used in Asian cuisine. Both are sold 
dried in Asian markets and are reasonably priced compared to many wild or cultivated 
mushrooms. Auricularia polytricha is variously called "wood ear," "tree ear," "black 
flmgus," or "milk nge" which was used for investigate its hypocholesterolemic effect 
(Cheung, 1996) in our project. The dried ear-shaped cap is medium sized, dull in texture, 
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and dark brown to black. The wavy lower surface has a contrasting powdery gray color. 
The stem is absent or rudimentary. It has no gills. It is a native of Asia and some Pacific 
Ocean islands in humid climates. Most major Asian countries successfully cultivate A. 
polytricha today. 
These fiingi are used for their crisp, snappy texture and their color rather than their taste. 
3.3 Results 
3.3.1 Extraction and Fractionation of Auricularia polytricha 
The lyophilized fungal powder makes up around 21% of the dry weight after 
removal of water in oven at 50°C. This fraction was the crude Auricularia polytricha 
Polysaccharide. After the first round of ethanol precipitation of 1 g / 20ml of 
polysaccharide solution by adding 1.5 X volume of absolute ethanol (1:1.5 v/v). The 
precipitate was subjected to lyophilization and the powder obtained was APP-A and the 
yield was 69.6%. Further 1.5 X volume of absolute ethanol was added to the remaining 
solution (1:3 v/v). The precipitate was subjected to lyophilization _and the powder 
obtained was APP-B and the yield was 22.8%. The results are shown in Table 3.1. 
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3.3.2 Determination of Carbohydrates Content 
The carbohydrate content of the extracted fractions were estimated with phenol-
sulfuric acid assay method. Dextran (M.W. 72,200) with concentration of 0.5 mg/ml, in 
dH20 was used as the standard. Crude APP, APP-A and APP-B were estimated to 
contain carbohydrate 51.8 土 5.6o/o, 39.4 土 4.2o/o, and 40.0 士 6.1o/o respectively. The 
results were listed in Table 3.2. 
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Table 3.1. The yield of different polysaccharide fractions isolated from the 
fungus Auricularia polytricha. 
Sample Mass (g) Percentage yield (%) 
Dried fungus 200.00 100.00 
Crude APP 42.60 21.30 100.00 
APP-A 29.67 69.60 
APP-B 9.71 22.80 
Dry powder of Auricularia polytricha was dissolved in a concentration of 1 
g/ 20ml, 1.5 volume of absolute ethanol (1:1.5 v/v) was added to the sample 
solution. After centrifiigation (3,000 x g, 30 min.), the precipitate obtained 
(APP-A) was dried by freeze-dryer. The remaining solution after 
centrifiigation was poured into 1.5 volume of absolute ethanol (1:3 v/v) to 
obtained APP-B after centrifugation and freeze-drying. 
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Table 3.2. The carbohydrate content of different polysaccharide fractions 
isolated from Auriculariapolytricha., Crude APP, APP-A and APP-B. 
Sample (0.5 mg/ml in dHsO) Percentage of carbohydrate (%) 
Dextran ~~ 100.0 
Crude APP 51.8 ±5.6 
APP-A 39.4 士 6.2 
APP-B 40.0 ±6.1 
The carbohydrate content was determined by phenol-sulfiiric acid method 
(Dubois, 1956) and absorbance was read at 490 nm using dextran (M.W. 
72,200) as a standard. 
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3.3.3 Determination of Protein Content 
Bicinchoninic acid protein assay (BCA) was adopted instead of the Bradford 
protein microassay (Bradford, 1976) and the Folin-Lowry method (Lowry et al, 1951). It 
is because the protein value determined by the Folin-Lowry method is affected by the 
presence of carbohydrate. Furthermore, the BCA method was the most sensitive assay 
compared to the other protein assay. The percentage of protein content of dextran, crude 
APP, APP-A and APP-B were 0.496%, 6.284%, 3.73% and 1.874% respectively. The 
total percentage yield of APP-A and APP-B was 92.4%. The total percentage protein 
content of APP-A and APP-b was 5.604%. If half of the total percentage protein content 
(APP-A + APP-B) was divided by the total percentage yield of APP-A and APP-B, the 
actual percentage protein content of the ethanol precipitated sample (APP-A and APP-B) 
is equal to 3.032%. When comparing the value to crude APP (6.284%), there is a great 
difference. Therefore, APP was found to contain extrinsic protein that is not associated 
with the polysaccharide chain. 
3.3.4 Determination of Uronic Acid Content 
The method (Chaplin & Kennedy, 1986) adopted was widely used but with 
disadvantages. Under the experimental conditions, neutral sugars at similar 
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concentration show 10% interference. In the estimation，D-glucurono-6, 3-lactone was 
used as standard. The uronic acid content of APP-A (5.92%) was much larger than APP-
B (3.46%). There is no loss of uronic acid after ethanol precipitation. The results were 
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Table 3.3. Determination of protein content (%) of dextran, crude 
Auricularia polytricha Polysaccharide (APP) and ethanol precipitated 
sample APP-A and APP-B obtained from crude APP. 
Protein Content (%) 
Dextran 0.496 士 0.05 
Crude APP 6.284 ±0.10 
APP-A 3.730 ±0.07 
APP-B 1.874 ±0.08 
The protein content was determined by BCA protein Assay (Walker, 1994) 
and absorbance was read at 540 nm using BSA as a standard. 
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Table 3.4. Determination of uronic acid content (%) of dextran, crude 
Auricularia polytricha Polysaccharide (APP) and ethanol precipitated 
sample APP-A and APP-B obtained form crude APP. 
Uronic Acid Content (%) 
Dextran 15.39± 1.10 
Crude APP 4.03 土 0.42 
APP-A 5.918 ±0.45 
APP-B 3.460 ±0.32 
The uronic acid content was determined by the carbazole reaction (Chaplin, 
1986) and absorbance was measured at 525 nm. 
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3.3.5 Determination of component sugars of AP Polysaccharide 
The sugar components of the crude APP were determined by a thin layer 
chromatographic method. The solvent system adopted was efficient in separating various 
monosugars such as glucose, mannose, xylose, galactose, arabinose and fucose, as 
shown in Fig. 3.1. The solvent system employed a mixture of ethylacetate, formic acid, 
acetic acid and distilled water in the ratio of 10:1:3:2. The monosaccharide standards 
showed a different Rf value in the thin layer chromatogram. After acid hydrolysis, the 
sample was tested in duplicate and the chromatogram showed that the crude sample 
contains mannose component. However, there is a tailing effect due to the residual acid 
in sample after acid hydrolysis. Tailing can be minimized by adding an equal molar of 
sodium hydroxide solution to the acid hydrolysate. 
As seen in Fig. 3.1, the result was not so satisfactory as only one monosaccharide 
can be seen. As we do not expect only one monosaccharide in the APP, we performed 
the monosaccharide analysis by a more sensitive system, HPLC. By HPLC, 
monosaccharide components of the APP can be tested quantitatively and qualitatively. 
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Fig. 3.1. The Thin Layer Chromatogram of monosaccharides. Xylose (1), 
glucose (2), galactose (3), mannose (4), fucose (6) and arabinose (7) were 
used as standard for locating the sample (5,8) monosaccharide obtained 
from acidic hydrolysis of polysaccharide (crude APP). The sample was 
tested in duplicate and the mobile phase was mixture of ethylacetate: formic 
acid: acetic acid: dHaO (10:1:3:2). 
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3.3.6 Fractionation of AP Polysaccharide 
The fractionation of AP polysaccharide was performed by size exclusion 
chromatography. Sepharose CL-4B was used. The results are shown in Fig. 3.2，Fig. 3.3， 
Fig. 3.4 and Fig. 3.5. Fig. 3.2 shows the elution profile of dextran with average 
molecular weight of 5,000K to 40，000K. As Sepharose CL-4B has a fractionation range 
of molecular weight of 30-5,OOOK, dextran was used to find the void volume of the 
column. The peak absorbance was at fraction 39, and then the void volume was 
approximately 117 ml (39 x 3 ml). From Fig. 3.3，the elution profile of crude APP 
shows two peaks, a broad peak and a sharp peak. The broad peak represents a elution 
volume of 114 - 255 ml (fraction 35-89) and sharp peak with elution volume of 300 -
351 ml (fraction 100-117). From Fig. 3.4，it shows the elution profile of ethanol 
precipitated polysaccharide APP-A (See section 2.2.1). The elution volume was 99 一 
240 ml (fraction 33-80). The elution profile was similar to the first peak of Fig. 3.3. 
From Fig. 3.5，it shows the elution profile of ethanol precipitated polysaccharide APP-B 
(See section 2.2.1). The elution volume was 105 - 321 ml (fraction 35-107). The elution 
profile was also similar to the first peak of Fig. 3.3. However, the sharp peak in Fig. 3.3 
does not appear in either Fig. 3.4 or Fig. 3.5. 
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Fig. 3.2. Elution Profile of Dextran (M.W>5000K) by Sepharose CL-4B 
size exclusion chromatography for estimation of void volume. 10 mg/ml of 
dextran was prepared and 1ml of dextran solution was added to column. 
The flow rate was set to 0.25 ml/min and 3 ml fraction was collected. 
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Fig. 3.3. Elution Profile of crude APP by Sepharose CL-4B size exclusion 
chromatography. 20 mg/ml of crude APP was prepared and 1ml of crude 
APP solution was added to column. The flow rate was set to 0.25 ml/min 
and 3 ml fraction was collected. 
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Fig. 3.4. Elution Profile of APP-A by Sepharose CL-4B size exclusion 
chromatography. 10 mg/ml of APP-A was prepared and 1ml of APP-A 
solution was added to column. The flow rate was set to 0.25 ml/min and 3 
ml fraction was collected. 
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Fig. 3.5. Elution Profile of APP-B by Sepharose CL-4B size exclusion 
chromatography. 10 mg/ml of APP-B was prepared and 1ml of APP-B 
solution was added to column. The flow rate was set to 0.25 ml/min and 3 
ml fraction was collected. 
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3.3.7 Determination of monosaccharide components of AP 
Polysaccharide by HPLC 
A simple and sensitive high-performance liquid chromatography (HPLC)-based 
method for complete monosaccharide composition analysis of polysaccharides is 
described in section 2.2.2.6. In this method, polysaccharides are first hydrolyzed using 
an optimized method to give the constituent monosaccharides, which are subsequently 
labeled with 1 -phenyl-3-methyl-5-pjyrazolone (PMP) as previously described by Honda 
et i (Honda et al, 1989). The labeled monosaccharides are separated by reverse-phase 
HPLC. 
Various monosaccharides behave differently during derivatization and hydrolysis. 
To adjust for these differences, both internal and external standards were used. A known 
amount of the internal standard, talose，was added to the samples before hydrolysis and 
its amount was used for monosaccharide quantification. An equal molar mixture of 
monosaccharides, treated under identical condition as the samples, was used as external 
standards to adjust for the loss of monosaccharides during acid hydrolysis and for any 
differences in PMP-labeling efficiency and HPLC analysis. By using both internal and 
external standards, accuracy of the analyses was greatly improved. 
In the experiment, the set of external standards that were included mannose, 
glucosamine, galactosamine, glucose, galactose, xylose and fucose. Talose was the 
internal standard. From Fig. 3.6，all the external and internal standards were well 
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separated excluding galactosamine. Galactosamine was included in HPLC analysis, but 
it cannot be resolved in the system. Since a large excess of PMP is used for 
derivatization, removal of the excess reagent by extraction prior to HPLC analysis is 
necessary. Butyl ether gives the best result for both extraction efficiency and product 
recovery. However, there is still a small amount of PMP left in the reaction mixture 
which is represented by the minor peak 1 in Fig. 3.6. 
Fig. 3.7，Fig. 3.8 and Fig. 3.9，showed that the monosaccharide composition of 
crude APP, APP-A and APP-B can be resolved by HPLC respectively. From these three 
figures，a similar profile was obtained and five monosaccharides have been resolved 
including the internal standard talose. Other four monosaccharides were mannose, 
glucose, galactose and xylose. However, there is a minor peak next to mannose and a 
minor peak between talose and glucose that cannot match any standard in Fig. 3.6. In 
Table 3.5, the predominant monosaccharide in crude APP, APP-A and APP-B was 
mannose; all three samples consisted of more than 65% of mannose. The amounts of 
monosaccharide in three samples were mannose, glucose, galactose and xylose in 
descending order. 
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Fig. 3.6. The RP-HPLC profile of standards including mannose (2), 
Glucosamine (3), internal standard talose (4), glucose (5), galactose (6), 
xylose (7), fucose (8). The small peak was PMP (1) left in the reaction 
mixture. Buffer A was 10% acetonitrile with 100 mM ammonium acetate 
and buffer B was 40% acetonitrile with 100 mM ammonium acetate with 
pH 5.5. The C-18 RP-column was equilibrate with 20% buffer B and the 
gradient was started from 20% buffer B to 75% buffer B within 90 min. 
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Fig. 3.7. The RP-HPLC profile of crude APP after acidic hydrolysis. 
Mannose (2), internal standard talose (4), glucose (5), galactose (6) and 
xylose (7) were resolved. Buffer A was 10% acetonitrile with 100 mM 
ammonium acetate and buffer B was 40% acetonitrile with 100 mM 
ammonium acetate with pH 5.5. The C-18 RP-column was equilibrate with 
20% buffer B and the gradient was started from 20% buffer B to 75% buffer 
B within 90 min. 
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Fig. 3.8. The RP-HPLC profile of APP-A after acidic hydrolysis. Mannose 
(2), internal standard talose (4), glucose (5), galactose (6) and xylose (7) 
were resolved. Buffer A was 10% acetonitrile with 100 mM ammonium 
acetate and buffer B was 40% acetonitrile with 100 mM ammonium acetate 
with pH 5.5. The C-18 RP-column was equilibrate with 20% buffer B and 
the gradient was started from 20% buffer B to 75% buffer B within 90 min. 
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Fig. 3.9. The RP-HPLC profile of APP-B after acidic hydrolysis. Mannose 
(2), internal standard talose (4), glucose (5), galactose (6) and xylose (7) 
were resolved. Buffer A was 10% acetonitrile with 100 mM ammonium 
acetate and buffer B was 40% acetonitrile with 100 mM ammonium acetate 
with pH 5.5. The C-18 RP-column was equilibrate with 20% buffer B and 
the gradient was started from 20% buffer B to 75% buffer B within 90 min. 
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Table 3.5. Monosaccharides Composition analysis of polysaccharide 
obtained from Auricularia polytricha. The value showed the amount (nmole) 
of monosaccharides in 0.12 mg of crude APP, APP-A and APP-B. 
Amount (nmole) 
Samples (0.12mg) Man GlcN Glc Gal Xyl Fuc 
Crude APP 2 2 5 . 1 4 ~ ^ ~ T O J l 2 4 . 1 5 ~ V i m 
APP-A 197.49 0.00 18.31 24.50 27.00 0.00 
APP-B 186.35 0.00 28.22 6.91 11.65 0.00 
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3.4 Discussion 
In the extraction of Auricularia polytricha polysaccharide, hot water was used. 
When a set of specified conditions was used in extraction of polysaccharide, the yield of 
polysaccharide extracted was higher than 20%. However, this value doesn't represent 
the total polysaccharide in the fungus. There is still a large amount of polysaccharide left 
in the residue. The carbohydrate content of Auricularia polytricha was more than 80% 
according to a previous study (PCK Cheung, 1997). For ethanol precipitation of crude 
Auricularia polytricha polysaccharide (APP), the total amount of APP-A and APP-B 
recovered was 92.4% and there is only a small amount of polysaccharide lost during the 
precipitation process. The efficiency in precipitation of polysaccharides must be due to 
the large molecular weight of APP. However, it is difficult to determine the molecular 
weight of the polysaccharide, as results showed that the peak was broad according to the 
CL-4B size exclusion profile. The molecular weight of APP was not larger than 5,000 K. 
APP was a heterogeneous mixture of various molecular weight polysaccharides. 
Moreover, the high viscosity of the APP solution also reflects the high molecular weight 
of APP. One gram per twenty milliliter of APP solution makes it difficult to flow and 
because it has a high water-holding capacity. However, APP is very soluble in water. 
The protein content of polysaccharide after ethanol precipitation decreased by 50%. It 
showed that some extrinsic protein was extracted together with APP. However, there is 
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Still some intrinsic protein that is associated with the polysaccharide chain to form 
proteoglycans. In fact, the protein and uronic acid content of the APP was insignificant-
no more than 5% of the total mass of the sample. The sugar component of the crude APP, 
APP-A and APP-B was determined in order to predict its structure. By thin layer 
chromatography, only mannose can be visualized. However, it does not imply that 
mannose was the only monosaccharide in APP. Therefore, a much more sensitive 
method (HPLC) was adopted in determining the monosaccharide composition of APP. 
In the determination, mannose, glucosamine, galactosamine, glucose, galactose, xylose 
and fucose were chosen as standards in the determination as these sugars are commonly 
found in fungal cell wall (Crook & Johnston, 1961). As expected, the results of the 
method showed that there was not only mannose in the hydrolysate of the APP. There 
was also glucose, galactose, xylose in the hydrolysate but with much more high 
percentage of mannose. The second most abundant monosaccharide component was 
glucose. In the HPLC analysis, the profile of crude APP, APP-A and APP-B did not 
differ by much. Therefore, all three samples have approximately the same 
monosaccharide composition. With the composition known, APP was predicted to be 
glucomannans, galactoglucomannans and galactomannans. Glucomannans is a 
polysaccharide which appears to be linear polymers with both mannose and glucose in 
the chain. Galactomannans are polysaccharides that have both galactose and mannose in 
the chain in varying proportions. Guar gum is a representative example of 
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Fig. 3.10. Chemical structures of Glucomannan and Galactoglucomannan. 
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Chapter Four: 
Protective, Therapeutic and Dose Effect of Auricularia 
polytricha Polysaccharide (APP) on Hyperlipidemia 
4.1 Introduction 
Water-soluble polysaccharides significantly lower serum or plasma cholesterol in 
humans and animals, whereas water-insoluble polysaccharides do not (Anderson & 
Tietyen-Clark, 1986). Soluble polysaccharides, the dietary fibers extracted from plant 
cell walls by hot water, include pectins, gums and some hemicelluloses. Insoluble 
polysaccharides include other hemicelluloses, cellulose and lignin (Southgate, 1977). 
Soluble polysaccharides are important components of most plant foods and comprise, on 
average，the following percentage of total dietary fibers for these food group: vegetable 
32%，cereals 32%, beans 25%, and fruits 38% (Anderson & Bridges, 1988). Soluble -
polysaccharides constitute about 30% of the total dietary fiber intake for a representative 
Western diet (Anderson et al, 1989). 
The mechanisms responsible for the hypocholesterolemic effects of soluble 
polysaccharides are not well delineated. In this chapter, the effects of water-soluble 
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Auricularia polytricha polysaccharide on blood cholesterol, triglyceride and liver 
cholesterol were reported. The first experiment (Experiment 1) is the protective effect of 
APP on hyperlipidemia. Hamsters were in normal status (not hyperlipidemia) and 2% of 
APP was added together with the high cholesterol diet in order to see whether APP can 
prevent elevation of body lipid. The second experiment (Experiment 2) is the therapeutic 
study of APP on hyperlipidemic status hamsters. Hamsters were boosted into high 
cholesterol status by feeding them with high cholesterol diet for four weeks. After that, 
hamsters were fed with high cholesterol diet with supplementation of 2% of APP for 
eight weeks in order to see whether APP can decrease body lipid level in pre-existing 
hyperlipidemia status. The third experiment is the dose-dependent response of APP on 
hyperlipidemia. This experiment aims to investigate the amount of APP on 
hypolipidemic effect and the toxicity of APP by measuring the AST and ALT enzyme 
activity. 
Golden Syrian hamster is a common rodent widely used as an experimental 
animal model in studying of cholesterol metabolism (Singhal et al, 1983)， 
atherosclerosis (Nistor et al, 1987) and hypocholesterolemic agents (Sugiyama et al, 
1995). Similar to human, its major plasma cholesterol carrier is LDL. By using 
electrophoresis in agarose gel, it is found that about 50% of hamster plasma cholesterol 
occurs in the LDL fraction. Moreover, hamster LDL cross-reacts with antibody raised 
against human LDL (Nistor et al, 1987). Other similarities include similar response to 
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different diets and drugs, and manner in handling biliary sterol secretion (Bocan & 
Guyton, 1985; Spady & Dietschy, 1985). 
The advantage in choosing hamsters is also partially due to their low rate of 
hepatic cholesterol synthesis. It is because increased hepatic influx of absorbed 
cholesterol could not be compensated in the species by down-regulation of cholesterol 
synthesis, but may alter hepatic cholesterol excretion (Berr et al, 1993). In this way, the 
factor from hepatic cholesterol synthesis can be negligible. 
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4.2 Results (Exp. 1) 
4.2.1 Body Weight and Food Intake 
The food intake and body weight in test group was just about 6% higher than 
control group. However, there was no significant difference in food intake and body 
weight gained among the three groups throughout the study period as showed in Table 
4.2. 
The present study showed that high dietary cholesterol increased the average 
liver weight in hamsters both in control and test (with 2% APP supplementation) group, 
as compared with that from the normal groups as shown in Table 4.1. However, there 
was no significant difference in average liver weight between test group and control 
group. Therefore, the increment of average liver weight was due to the high cholesterol 
and high fat diets. 
4.2.2 Effect of APP Supplementation on Hepatic Cholesterol 
In the protective study, the control group was fed with high cholesterol and fat 
diets while the test group was fed with the same diet with supplementation of 2% APP. 
This experiment was aimed to see whether APP supplementation could prevent rising of 
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body cholesterol level. The result showed that the hepatic cholesterol of the test group 
was significantly lower than control group. Liver cholesterol was decreased by 29.03% 
in test group when compared with control group as shown in Fig. 4.1 and a typical gas-
liquid chromatogram of tissue cholesterol was shown in Fig. 4.2. However, the hepatic 
cholesterol level in both test and control group were significantly higher than the normal 
group. Therefore, APP supplemented diet can decrease hepatic cholesterol but not 
reduce it to normal levels. 
4.2.3 Effect of APP Supplementation on Plasma TC, HDL-C and TG 
Fasting plasma total cholesterol was significantly decreased by 12.7% (P<0.05) 
in hamsters fed with 2% APP-supplemented diet (test group) for 4 weeks, as compared 
with control group (Fig. 4.3). The plasma HDL-C, in the test group was also 
significantly decreased by 10.3% (P<0.01) as compared with the control group (Fig. 4.3). 
However, there was no significant difference in plasma TG between control and test 
group (Fig. 4.4). Moreover, plasma TC, HDL-C and TG of test and control group were 
significantly higher than that of normal group. -
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Table 4.1. Effect of APP on the average liver weight of six experiments. 
Liver weight in the row was the average of experiments 4 and 5. The 
diets based on the high cholesterol diet (C) with the supplementation of 1% 
APP (1%), 2% APP (2%), 4% APP (4%), 1% sodium acetate (Ac), 1% 
sodium propionate (Pr), 1% sodium butyrate (Bu) and 0.5% sodium acetate 
plus 0.5% sodium propionate (Ac,Pr). The normal diet (N) contains no 
cholesterol and was provided by Laboratory Animal Service Center (LASC). 
For experiment 2, the first data was the liver weight at week 8 while the 
latter one was the one at week 12. 
Average Liver Weight (g) 
Exp. N 1% 2 % 4 % C Ac Pr Bu Ac，Pr 
i ^ / 4M 1 / / / / ” 
9 4.13/ 5.16/ , 4.82/ , 
丄 � � / / / / 
4.80 6.07 6.14 
3 3.85 4.60 / 4.10 4.67 / / / / 
4,5 3.99 / 6.03 / 4.69 4.72 3.88 4.67 4.51 
6 75.47 / 112.35 / -127.23 / / / / 
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Table 4.2. Effect of APP on body weight and food intake of hamsters. Male 
hamsters were fed with normal diet, test diet (with 1%, 2% or 4% APP 
supplementation) and control diet. The experimental period for experiment 
1 and 3 were four weeks. For experiment 2, all three groups of hamsters 
were fed with control diet (high cholesterol diet) for 4 weeks. Then, the 
hamsters were divided into normal, test and control group and fed with 
different diet for eight weeks more. The first data of final body weight was 
corresponding to week 8 and the second was corresponding to week 12. 
Experiment 1 
Normal Test (2%) Control 
Initial body weight (g) 101.60 士 6.87 105.90 土 7.07 107.04 士 3.39 
Final body weight (g) 154.34 士 8.49 155.87 土 9.58 147.44 土 7.30 
Food intake (g/day) 7.34 土 0.56 8.03 土 0.63 7.53 土 0.53 
Experiment 2 
Normal Test (2%) Control 
Initial body weight (g) 102.60 土 6.07 106.85 土 2.70 106.52 土 7.77 
Final body weight (g) 165.12 土 13.21/ 179.90 土 12.35/ 166.51 ± 16.72/ 
166.35 ± 12.32 181.44 ± 14.36 163.12 士 20.05 
Food intake (g/day) 7.21 ±0.43 7.74± 1.11 7.37 ±0.81 
Experiment 3 
Normal Control Test(l%) Test (4%) 
Initial body weight (g) 102.60 ±6.45 97.10 士 7.47 102.32 ±6.25 100.54 ±5.91 
Final body weight (g) 150 ±5.23 150.12 ±5.68 152.15 ±6.35 161.80 ±4.17 
Food intake (g/day) 7.30 ± 0.55 7.02 土 0.57 7.25 土 0.46 7.57 土 0.57 
* Data are expressed as means 士 SD. 
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Fig. 4.1. Effect of APP on the liver cholesterol level. Male hamsters were 
fed with normal diet, test diet (with 2% APP supplementation) and control 
diet. After 4 weeks, liver cholesterol content was analyzed by GLC. 
(* P<0.05) 
=—__=_ 90 







0 . l \ -
0 5 1 0 1 5 
min 
Fig. 4.2. Gas-liquid chromatographic profile of hepatic cholesterol and 
internal standard (stigmastanol). -
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Fig. 4.3. Effect of APP on the plasma total cholesterol and HDL-cholesterol 
level. Male hamsters were fed with normal diet, test diet (with 2% APP 
supplementation) and control diet. After 4 weeks, plasma total cholesterol 
and HDL-cholesterol were measured by enzymatic diagnostic kit. (* P<0.05) 
(** P<0.01) 
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Fig. 4.4. Effect of APP on the plasma triglyceride level. Male hamsters 
were fed with normal diet, test diet (with 2% APP supplementation) and 
control diet. After 4 weeks, plasma triglyceride content was measured by 
enzymatic diagnostic kit. 
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4.2.4 Effect of APP Supplementation on Fecal Output of Neutral 
Sterols 
The neutral sterols included coprostanol, coprostanone, cholesterol, 
dihydrocholesterol, campersterol, stigmasterol (internal standard), P-sitosterol and 
stigmastanol were separated and quantified by GLC (Fig. 4.5). 
From Fig. 4.5.1, the fecal neutral sterol at week 1 is much higher than at week 
2,3 and 4. The percentage increase in fecal neutral sterol was 4.33% and 11.91% at week 
2 and 3 respectively. However, there is no difference between the test and control groups 
at week 4. 
4.2_5 Effect of APP Supplementation on Fecal Output of Acidic 
Sterols 
The acidic sterols included lithocholic acid, deoxycholic acid, cholic acid, 
hyodeoxycholic acid (internal standard) and ursodeoxycholic acid were resolved and 
quantified by GLC (Fig. 4.6). 
In this study, from Fig. 4.6.1，the fecal acidic sterol at week 1 is also much higher 
than at week 2, 3 and 4. The percentage increase in fecal acidic sterol was 38.77%, 
42.17% and 46.52% at week 2,3 and 4 respectively. 
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Fig. 4.5. Gas liquid chromatographic profile of fecal neutral sterols. 
Identification of peaks: 1- coprostanol, 2- coprostanone, 3- cholesterol, 4-
dihydrocholesterol, 5- campersterol, 6- stigmasterol (internal standard), 7-
P-sitosterol, 8- stigmastanol. See section 2.2.6 for the conditions of 
separation. 
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Fig. 4.6. Gas liquid chromatographic profile of fecal acidic sterols. 
Identification of peaks: 1_ lithocholic acid, 2- deoxycholic acid, 3- cholic 
acid, 4- hyodeoxycholic acid (internal standard), 5- ursodeoxycholic acid. 
See section 2.2.6 for the conditions of separation. 
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Fig. 4.5.1. Total fecal neutral sterol in the control and test group. Test group 
diet was supplemented with 2% APP. 
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Fig. 4.6.1. Total fecal acidic sterol in the control and test group. Test group 
diet was supplemented with 2% APP. 
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4.3 Discussion (Exp. 1) 
From the results, there was no significant difference in food intake and final 
body weight have no significant difference among the three groups. However, high 
dietary cholesterol and fat diets in both test and control group increased the average liver 
weight significantly as compared with the control group. 
There are several ways that hepatic cholesterol can be increased. Hepatic 
cholesterol can be increased by an increase in receptors for low-density lipoprotein, LDL， 
on the surface of the hepatocytes, by increasing the high-density lipoprotein cholesterol, 
HDL-C, in blood as it can mediates reverse transport of cholesterol, the process by 
which cholesterol is removed from sites of deposition in the extra-hepatic tissues and is 
delivered back to the liver (Renn, 1997). Recent studies also showed that absorption of 
dietary cholesterol increase linearly with an increased intake of dietary cholesterol. Bile 
acid excreted into intestine can be reabsorbed and carried back to liver by albumin for 
cholesterol synthesis (Sehayek et al, 1998). Finally, de novo hepatic synthesis of fresh 
cholesterol can be initiated via increased activity of HMG-CoA Reductase, the key 
enzyme regulating the biosynthesis of cholesterol. However, there is only one pathway 
by which hepatic cholesterol can be removed away from liver. Hepatic cholesterol can 
be oxidized into bile acid by cholesterol-7a-hydroxylase (Souidi et al, 1998) and 
excreted as bile into intestine, then out of the body. 
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Both test and control groups showed a significant increase in hepatic cholesterol 
as compared to the normal group. This was due to the high cholesterol and fat diets in 
both groups as absorption of dietary cholesterol increased linearly with an increased 
intake of dietary cholesterol. However, the test group showed about 30% decrease in 
liver cholesterol as compared to the control group. Moreover, the plasma total 
cholesterol and high-density lipoprotein cholesterol level of the test group showed a 
significant decrease of more than 10% when compared with the control group. However, 
there was no significant difference in plasma triglyceride level between the test group 
and control group. 
The present results showed that dietary APP supplementation generally increased 
the fecal excretion of neutral sterols. However, the difference is small. The different 
neutral sterols identified in feces were possibly the products of the bacterial modification 
of cholesterol in gut (Kellogg, 1974). These fecal neutral sterols are capable to diminish 
the intestinal cholesterol absorption, by which they lower the capacity of micelles and 
displace cholesterol from micellar binding during absorption (Ikeda & Sugano, 1983; 
Heinemann et al, 1991). 
Three bile acids make up the majority of the total bile acids present in bile: 
cholic acid 40%, chenodeoxycholic acid 40% and deoxycholic acid 20% (Hofmann, 
1976). Small amounts of ursodeoxycholic acid and lithocholic acid are also present 
(Einarsson & Angelin, 1986). The GLC profile showed that there is large amount of 
lithocholic acid. Lithocholic acid arises via bacterial dehydroxylation of 
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chenodeoxycholic acid, predominantly, in the colon; and is absorbed by passive 
mechanisms to enter the portal circulation for transport back to liver. Therefore, it is 
predicted that the bacterial action is huge at colon. The results showed that dietary APP 
supplementation increased the fecal excretion of acidic sterols (Gallaher & Schneeman, 
1986). However, the mechanism was not clear. 
Auricularia polytricha polysaccharide showed a marked hypocholesterolemic 
effect in plasma and liver in spit of its high cholesterol level as compared to the normal 
group. Therefore, APP can more or less protect the body from hypercholesterolemia. 
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4.4 Results (Exp. 2) 
4.4.1 Body Weight and Food Intake 
For the hamsters at week 8 and 12，there is no significant difference between the 
control and normal groups in food intake and body weight. For test group, the food 
intake was 5% more than control group with body weight 11% heavier than control 
group as shown in Table 4.2. 
This study also showed that high dietary cholesterol increased the average liver 
weight in hamsters both in control and test (with 2% APP supplementation) group, as 
compared to the normal groups as shown in Table 4.1. Both test and control groups have 
an average liver weight of more than 15% and 20% higher than normal group at week 8 
and 12 respectively. However, there was no significant difference in average liver 
weight between the test group and control group. Therefore, the increment of average 
liver weight was also due to the high cholesterol and high fat diets. 
4.4.2 Effect of APP Supplementation on Hepatic Cholesterol 
In the therapeutic study, hamsters were fed with high cholesterol diet for four 
weeks in order to boost it into hyperlipidemic status. After that, test group was fed with 
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high cholesterol diet with 2% APP supplementation for another eight weeks while 
control group was still fed with high cholesterol diet. This experiment was aimed to see 
whether APP supplementation could decrease cholesterol level in hamster consequently. 
From the results, liver cholesterol was decreased by 14.3% (P<0.05) and 21% 
(P<0.01) in the test group at week 8 and 12 respectively, as compared with control group. 
However, both test and control groups have much higher liver cholesterol level than the 
normal group at both week 8 and 12. 
4.4.3 Effect of APP Supplementation on Plasma TC and TG 
Fasting plasma TC was significantly decreased by 19.3% (P<0.05) and 26.3% 
(P<0.02) in the test group at week 8 and 12 respectively, as compared with control group. 
However, TC in test and control were significantly higher than normal group at both 
week 8 and 12. The plasma TG level of the test group was higher than the control group 
at week 8 and lower than control group at week 12 but it was not statistically significant 
(Fig. 4.6). 
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4-4.4 Effect of APP Supplementation on Plasma HDL-C and LDL-C 
Fasting plasma HDL-C was significantly decreased by 17.1% (P<0.02) and 20% 
(P<0.05) in the test group at week 8 and 12 respectively, as compared with control group. 
However, HDL-C in test and control were significantly higher than normal group at both 
week 8 and 12. Fasting plasma LDL-C was significantly decreased by 21.41% (P<0.02) 
and 47.1% (P<0.01) in test group at week 8 and 12 respectively, as compared with 
control group. However, HDL-C in test and control were significantly much higher than 
normal group at both week 8 and 12 (Fig. 4.7). 
Table 4.3 shows the LDL/HDL ratio; the test group has a LDL/HDL ratio of 
5.18% and 33.93% lower than the control group at week 8 and 12 respectively. However, 
the test group has a ratio of 8.75% and 18.16% higher than normal group at week 8 and 
12 respectively. 
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Fig. 4.7. Effect of APP on the liver cholesterol level. All male hamsters 
were fed with control diet (high cholesterol diet) for four weeks in order to 
push the hamsters into hyperlipidemic status. Then, hamsters were divided 
into three groups fed with normal diet, test diet (with 2% APP 
supplementation) and control diet respectively. After eight and twelve 
weeks, the liver cholesterol content was determined by GLC. (* P<0.05) 
(** P<0.01) 
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Fig. 4.8. Effect of APP on plasma total cholesterol and triglyceride level. 
All male hamsters were fed with control diet (high cholesterol diet) for four 
weeks in order to boost the hamsters into hyperlipidemic status. Then, 
hamsters were divided into three groups fed with normal diet, test diet (with 
2% APP supplementation) and control diet respectively. After eight and 
twelve weeks, the plasma cholesterol content was determined by enzymatic 
diagnostic kit. (* P<0.02) (** P<0.05) 
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Fig. 4.9. Effect of APP on plasma HDL-cholesterol and LDL-cholesterol 
level. All male hamsters were fed with control diet (high cholesterol diet) 
for four weeks in order to push the hamsters into hyperlipidemic status. 
Then, hamsters were divided into three groups fed with normal diet, test 
diet (with 2% APP supplementation) and control diet respectively. After 
eight and twelve weeks, the plasma HDL- and LDL-cholesterol content was 
determined by enzymatic diagnostic kit. (* P<0.01) (** P<0.02) 
(***P<0.05) 
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Table 4.3. Effect of APP on the LDL/HDL Cholesterol Ratio. For 
experiment 2, all male hamsters were fed with control diet (high cholesterol 
diet) for four weeks in order to push the hamsters into hyperlipidemic status. 
Then, hamsters were divided into three groups fed with normal diet, test 
diet (with 2% APP supplementation) and control diet respectively. For 
experiment 3，male hamsters were fed with normal diet, control diet (high 
cholesterol diet), test diet (with 1% and 4% APP supplementation). 
LDL/HDL-Cholesterol Ratio 
— N o r m a l Test (2%) Control 
Experiment 2 
Week 8 0.7254 0.7889 0^320 
Week 12 0.7532 0.8900 1.347 
LDL/HDL-Cholesterol Ratio 
Normal Control Test(l%) Test (4%) 
Experiment 3 
Week 4 “ 1.1328 1.8771 1.2177 L I O ^ 
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4.5 Discussion (Exp. 2) 
In experiment 1, the protective effect of APP was studied. The result showed that 
APP could prevent hypercholesterolemia in spit of high cholesterol level as compared 
with normal hamsters. In this experiment, the therapeutic effect of APP was studied. The 
aim was to see whether APP could lower cholesterol level in a pre-existing 
hypercholesterolemic state. The therapeutic effect of APP was tested at week 8 and 
week 12 in order to see whether it has progressive improvement on 
hypercholesterolemia (Hunninghake et al, 1994; Jensen et al, 1997). 
The interrelations among diet-related risk factors and coronary heart diseases 
(CHD), particularly that between diet and plasma lipoproteins, were important for our 
studies. Cholesterol is transported in plasma by lipoprotein. The majority of plasma 
cholesterol is in low-density lipoprotein (LDL); hence elevations in total cholesterol 
reflect elevations in LDL. LDL appears to be atherogenic, because a high level of this 
lipoprotein is a significant risk factor for coronary heart disease (CHD) (Wilson et al, 
1980). The remaining cholesterol in plasma in the fasting state is present in HDL. There 
is a clear inverse relation between HDL concentration and risk for CHD, such that HDL 
appears to be antiatherogenic (Abbott et al, 1988). Thus, high levels of total，and 
particularly LDL, cholesterol increase CHD risk; low levels of HDL may do so fiirther. 
Therefore, reduction of LDL level is associated with reduced CHD risk (, 1984)，slowing 
of atherosclerotic progression (Blankenhom et al, 1987; Cashin-Hemphill et al, 1990; 
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Brown et al, 1990; Kane et al, 1990), and even, in some recent coronary angiographic 
studies, regression of established atherosclerotic lesions (Brown et al, 1990; Kane et cd, 
1990). Increases in HDL level may also be associated with reduced CHD risk (Gordon et 
al, 1989). Therefore, the ratio of LDL to HDL is a better reflection of CHD. The lower 
ratio gives a lower risk of CHD. 
From the results, there are progressive decreases in hepatic cholesterol, total 
cholesterol, LDL-C and HDL-C. Moreover, LDL/HDL ratio in test group was 
significantly decreased by 5.18% and 33.93% at week 8 and 12 respectively as 
compared with control group. Therefore, APP has a positive effect on therapeutic 
response to hypercholesterolemia. Also, APP has an antiatherosclerotic effect on 
hypercholesterolemic body as it can lower LDL/HDL ratio significantly. The 
antiatherosclerotic effect of APP can be confirmed by regression of established 
atherosclerotic lesions. However, with the constraint of the size of aorta of hamster, the 
lesions were difficult for visualization. This methodology was performed in later 
experiment using rabbit as animal model. 
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4.6 Results (Exp. 3) 
4.6.1 Body Weight and Food Intake 
There is only a small difference in food intake and body weight among test group 
(both 1% and 4% APP supplementation), control and normal group. For test group, the 
food intake was slightly more than control group with a larger difference for test group 
with 4% APP supplementation. Moreover, increased food intake resulted in increased 
body weight as shown in Table 4.2. 
In this experiment, the average liver weight of the test group and control was 
significantly increased as compared with the normal group. The test group had a lower 
average liver weight than control group. The results showed that increased percentage of 
APP has a lower average liver weight (Table 4.1). 
4.6.2 Dose Response of APP Supplementation on Hepatic 
Cholesterol 
In dose-dependent response study, hamsters were fed with high cholesterol diets 
with supplementation of 1% APP (low) and 4% APP (high dose) for four weeks. 
From the results, liver cholesterol of the test and control groups were 
significantly higher than normal group (> 3 folds). However，the test group had lower 
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hepatic cholesterol than the control group. The liver cholesterol content was decreased 
by 16.44% and 41.83% significantly (PO.Ol) in test group with 1% and 4% APP 
supplementation respectively (Fig. 4.10). 
4.6.3 Dose Response of APP Supplementation on Plasma TG 
From Fig. 4.11，fasting plasma TG of the test group and control group were 
significantly higher than normal group. However, the test group had lower TG than the 
control group. The plasma TG content was decreased by 15.75% and 10.41% 
significantly (P<0.01) in test group with 1% and 4% APP supplementation respectively. 
4.6.4 Dose Response of APP Supplementation on Plasma HDL-C and 
LDL-C 
From Fig. 4.12, fasting plasma HDL- and LDL-cholesterol of the control was 
significantly higher than the test group and normal group (P<0.05). However, the level 
of this two parameter has no significant difference between test group and normal group 
in this experiment. The plasma LDL-C content was decreased by 18.51% and 23.73% 
significantly (P<0.05) in test group with 1% and 4% APP supplementation respectively. 
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Moreover, the plasma HDL-C content was decreased by 27.7% and 30.15% significantly 
(P<0.05) in test group with 1% and 4% APP supplementation respectively. 
Table 4.3 shows the LDL/HDL ratio, test group has a LDL/HDL ratio of35.13% 
and 41.4% lower than control group with 1% and 4% APP supplementation respectively. 
Test group with 1% APP supplementation had a LDL/HDL ratio of 7.49% higher than 
normal group. However, there was no significant difference between test group with 4% 
APP supplementation and control group. 
4.6.5 Dose Response of APP Supplementation on ALT and AST 
Activity 
From Fig. 4.13, the results showed that plasma ALT activity has no significant 
difference among normal, control and test group. For AST activity, the level of normal 
group was lower than test and control for a less extent. However, there was no 
significant difference between test and control groups. 
4.6.6 Dose Response of APP Supplementation on Fecal Output of 
Neutral and Acidic Sterols 
From Fig. 4.14，the results showed that the fecal neutral sterol output at week 1 is 
much higher than at week 2, 3 and 4. The difference of fecal neutral sterol excretion is 
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small between control and test group (both 1% and 4% APP supplementation). In 
general, the neutral sterol in test group is higher than control group. However, we cannot 
draw a conclusion whether increase the percentage of APP can increase the amount of 
neutral sterol excretion. 
From Fig. 4.15，the results showed that the fecal acidic sterol output at week 1 is 
also much higher than at week 2，3 and 4. There is difference in fecal acidic sterol 
excretion among control and test groups (both test group) (Favier et al, 1997). 
Supplementation with APP always has higher fecal acidic sterol excretion. However, we 
have no conclusive pattern whether increase the percentage of APP can increase the 
amount of neutral sterol excretion. At week 2 and 4, test group with 4% APP 
supplementation have higher acidic sterol excretion than 1% of APP. However, at week 
3，1% APP supplementation has higher acidic sterol excretion than 4% APP. 
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Fig. 4.10. Dose-dependent response of APP on hepatic cholesterol level. All 
male hamsters were fed with normal diet, control diet and test diet (with 1% 
and 4% APP supplementation). After four weeks, the liver cholesterol 
content was analyzed by GLC. (*P<0.01) 
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Fig. 4.11. Dose-dependent response of APP on plasma triglyceride. All 
male hamsters were fed with normal diet, control diet and test diet (with 1% 
and 4% APP supplementation). After four weeks, the plasma total 
cholesterol and triglyceride was determined by enzymatic diagnostic kit. 
(*P<0.01) 
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Fig. 4.12. Dose-dependent response of APP on plasma LDL-C and HDL-C. 
All male hamsters were fed with normal diet, control diet and test diet (with 
1% and 4% APP supplementation). After four weeks, the plasma LDL-C 
and HDL-C was determined by enzymatic diagnostic kit. (*P<0.05) 
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Fig. 4.13. Dose-dependent response of APP on plasma ALT and AST. All 
male hamsters were fed with normal diet, control diet and test diet (with 1% 
and 4% APP supplementation). After four weeks, the plasma ALT and AST 
was measured by enzymatic diagnostic kit. 
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Fig. 4.14. Total fecal neutral sterol in the control and test group with APP 
supplementation. Test group diet was supplemented with 1% or 2% APP. 
119 
Protective, Therapeutic and Dose Response Study 
_ 6 n 
'oT “ 
o • Control 111% APP 國 4。/。APP 
在 5_ —— 
D) 、 • 
2 . ：； ‘ H - 5 
2 3 - ‘ h 〈 ； I 
？ , ‘ r - I P 卜 
lu 
r J L I L J L I l 
Week 1 Week 2 Week 3 Week 4 
Fig. 4.15. Total fecal acidic sterol in the control and test group with APP 
supplementation. Test group diet was supplemented with 1% or 2% APP. 
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4.7 Discussion 
In this experiment, the dose-dependent response of APP was under investigated 
(Bobek et al, 1998). One percent and four percent of APP was used to test whether there 
is a dose-dependent response relationship between amount of APP and its hypolipidemic 
effect. Moreover, the toxicity of APP was also measured by using AST and ALT assay. 
Aspartate Aminotransferase (AST, EC 2.6.1.1) is widely distributed in tissues 
with highest concentration in liver, heart and skeletal muscle. Acute destruction of these 
tissues results in release of sizeable amounts of AST into systemic circulation. Alanine 
Aminotransferase (ALT, EC 2.6.1.2) is widely distributed in certain tissues with highest 
concentration in liver, kidney and heart. Above normal ALT values are also associated 
with toxic hepatitis, infectious mononucleosis and intrahepatic cholestasis. As a rule, 
ALT levels rise whenever liver cells are damaged. Therefore, the plasma AST and ALT 
were tested in order to find out whether APP exhibited toxic effect to liver cells. 
From the results, we found that the hepatic cholesterol content decreased with 
increased percentage of APP. The triglyceride level of test group was significantly lower 
than in control group but this result was conflicted with the previous study. In previous 
studies，the plasma triglyceride level always has no significant difference between test 
and control groups. For LDL-C level, test group was significantly lower than control 
group and with similar level with normal group. However, it does not show any dose-
dependent response relationship between percentage of APP supplementation and extent 
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of decrease in LDL-C. For HDL-C, test group was significantly higher than control 
group with a level even higher than normal group. Also, it does not show dose-
dependent response effect. In spite of increased HDL-C, we are only concentrated on the 
atherosclerotic index, LDL/HDL ratio. This ratio is a better reflector of the degree of 
atherosclerosis. The test group showed much lower ratio than control group and the level 
was approximately equal to normal group for 4% APP supplementation. Therefore, this 
implies that APP supplementation can improve the state of atherosclerosis but this does 
not mean increase the amount of APP can have greater improvement. For ALT assay, it 
does not show significant difference among normal, control and test group. The ALT 
level of control group was only slightly higher than test group. From the result of AST 
assay，the same phenomenon appears. Therefore, the results showed that APP does not 
show any toxic effect up to recent investigations. 
From the results of fecal sterol output, similar conclusion was drawn. 
Supplementation of APP generally increases neutral sterol excretion with small extent 
while greatly increase acidic sterol excretion. The purpose of this experiment is to test 
whether increase amount of APP can increase the sterol output. As a result, there is no 
direct relationship between percentage APP supplemented and both acidic and neutral 
sterol excretion. 
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Chapter Five: 
Hypolipidemic Effect of Short Chain Fatty Acids 
5.1 Introduction (Exp. 4,5) 
An important physiological action of dietary fiber is the lowering of plasma 
cholesterol levels (Anderson, 1985). Inhibition of the absorption of bile acids and 
cholesterol, or suppression of cholesterol synthesis, may be involved in the effects of 
dietary fiber on lowering blood cholesterol. Previous investigations (Carr et al, 1996; 
Gallaher et al, 1993) showed that the viscosity of dietary fiber is related to its cholesterol 
lowering effect in hamsters fed with cholesterol-supplemented diets. However，other 
research (Younes et al, 1995) demonstrated that, in rats，a fermentable component, 
resistant starch, lowers plasma cholesterol levels more effectively than Cholestyramine� . 
Ingestion of highly fermentable dietary fiber，sugar-beet fiber (SBF), decreases 
plasma cholesterol concentrations in rats <Aritsuka et al, 1989; Johnson et al, 1990), and 
the effect requires the bacterial actions of the large intestine (Nishimura et al, 1993). 
Recent studies demonstrated that a short-chain fatty acid mixture simulating the cecal 
fermentation products of SBF lowered plasma cholesterol levels to a degree similar to 
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that obtained by SBF feeding in rats (Hara et al, 1998a). This finding suggests that the 
suppressive effect of SBF on plasma cholesterol levels is at least partly caused by the 
cecal fermentation products, short-chain fatty acid (SCFA). One of these fermentation 
products, propionate, is viewed as a potential effective agent for lowering plasma 
cholesterol levels (Chen et al, 1984; Nishina & Freedland, 1990). However, the results 
of studies examining the effects of propionate on cholesterol metabolism are 
controversial (Berggren et al, 1996; Kishimoto et al, 1995). Also, studies showed that 
acetate was an effective component of the SCFA mixture for lowering plasma 
cholesterol levels, whereas propionate was not (Hara et al, 1998a). 
The purposes of these studies (Experiment 4 and 5) were to determine whether 
the artificial SCFA decrease plasma cholesterol concentration and liver cholesterol 
(Moundras et al, 1994). Moreover, the effect of SCFA on de novo cholesterol synthesis 
was also examined by measuring the activity of HMG-CoA Reductase which is the key 
enzyme regulating the rate determining step in de novo cholesterol synthesis. 
In this investigation, two separated experiments were conducted (Experiment 4 
and 5) because fasting is needed for measuring plasma TG, HDL-C and LDL-C 
(Experiment 4). However, in measuring HMG-CoA Reductase activity, fasting is not 
needed because diets may have direct and acute response on this enzyme. Thus, the 
hamsters were not fasted in experiment 5. In experiment 5, one unit of activity is defined 
as one pmol/min/mg protein. The experimental conditions and diets were the same in 
these two experiments. 
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5.2 Results (Exp. 4,5) 
5.2.1 Body Weight and Food Intake 
For Pr, test and control group, the food intake was slightly higher than the other 
groups. However, there is no significant difference in body weight among all groups as 
shown in Table 5.1. 
From Table 4.1，Pr and normal group has the lowest average liver weight ( � 4 g) 
while the test group has the highest liver weight ( � 6 g) and the other groups have a 
medium average liver weight (-4.5 g). 
5.2.2 Effect of SCFA Supplementation on Hepatic Cholesterol 
From the results, liver cholesterol was decreased significantly by 29.2% (Ac)， 
22.9% (Pr), 31.7% (Bu), 20.7% (Ac,Pr) and 38.4% (Test) as compared with the control 
group as shown in Fig. 5.1. 
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Table 5.1. Effect of APP and SCFA on body weight and food intake of 
hamsters and rabbits. For experiment 4 and 5, male hamsters were fed with 
normal diet, short chain fatty acids diet (with supplementation of 1% of 
sodium acetate (Ac), sodium propionate (Pr), sodium butyrate (Bu), 0.5% 
of each sodium salt of acetate and propionate (Ac,Pr) and control diet for 
four weeks. For experiment 6, male New Zealand rabbits were fed with 
normal diet, test diet (with 2% APP supplementation) and control diet for 
twelve weeks. 
Experiment 4,5 
Ac Pr Bu 
Initial body weight (g) 104.24 ±7.87 104.02 ± 11.63 112.32 土 8.66 
Final body weight (g) 143.72 土 8.57 137.38 士 8.54 144.1 土 6.02 
Food intake (g/day) 7.49 土 0.80 8.21 ±0.82 7.47 ± 1.36 
Ac,Pr Test (2%) Control 
Initial body weight (g) 109.84 土 9.85 110.30 土 6.44 100.44 士 3.08 
Final body weight (g) 141.32 土 8.05 148.96 士 4.07 144.8 土 7.17 
Food intake (g/day) 7.38 ±0.95 8.66 土 1.29 8.15 士 1.59 
Experiment 6 
Normal Test (2%) Control 
Initial body weight (Kg) 3.50 土 0.00 3.38 土 0.26 3.30 土 0.27 
Final body weight (Kg) 3.70 ±0.16 3.53 ±0.49 3.06 ±0.17 
Food intake (g/day) 101.24 土 15.66 86.83 土 16.60 86.77 土 12.15 
126 
Hypolipidemic Effect of SCFA 
35 n 
30 - 口 
o 25 - f * T 
1= L； * > ‘ 
_ IS ‘ ~ ~ N * » 
； r ~~I . • T 
o 20 - 卜 ‘ i . * 
S I 1 ？' f: p i 
</> I—‘―I ’ . 
o 15 - 4 J : : , ；': 
O k >\ 
g r J 多： 
10 - ； J -
I * I r 
% A u “ 、 
I ^  ‘ I I t- i 
5 - 丨 \ I ' , 
I 老 
‘ ^ 
•' f . 
n I 'I , , _ J � 
U i I i 1 1 1 i I 
Normal Control Ac Pr Bu Ac,Pr Test 
(2%) 
Fig. 5.1. Effect of APP and SCFA on liver cholesterol level. Male hamsters 
were fed with normal diet, control diet, short chain fatty acids diet (with 
supplementation of 1% of sodium acetate (Ac), sodium propionate (Pr), 
sodium butyrate (Bu), 0.5% of .each sodium salt of acetate and propionate 
(Ac,Pr) and test diet (with supplementation of 2% APP) for four weeks. 
(*P<0.01) 
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5.2.3 Effect of SCFA Supplementation on Plasma TG, HDL-C and 
LDL-C 
There is no significant difference among all the groups except for the normal 
group in plasma TG level as shown in Fig. 5.2. Fasting plasma LDL-C was decreased by 
38.16% (Ac), 12.86% (Pr)，31.63% (Ac,Pr) and 40.4% (Test) significantly as compared 
with control group (Fig.5.3). However, there is no significant difference between group 
Bu and control. For group Ac and test group, the LDL-C has almost reached the normal 
level. For HDL-C, only group Ac and test group showed significant difference when 
compared with control group. HDL-C was increased by 10.9% and 18.5% in group Ac 
and test group respectively (Fig. 5.3). The LDL/HDL ratio was decreased by 43.94% 
(Ac)，9.09% (Pr), 7.58% (Bu), 36.36% (Ac,Pr) and 50.00% (test) compared with control 
group. 
5.2.4 Effect of SCFA Supplementation on AST and ALT Activity 
From Fig. 5.4，there is no significant difference for AST activity among all 
groups except group Bu as compared with control group, the level of AST activity was 
increased by 181.11%. For ALT activity, there is also no significant difference among 
all the groups except group Bu when compared with control group, the level of ALT 
‘ activity was increased by 66.93%. 
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Fig. 5.2. Effect of APP and SCFA on plasma triglyceride level. Male 
hamsters were fed with normal diet, control diet, short chain fatty acids diet 
(with supplementation of 1% of sodium acetate (Ac), sodium propionate 
(Pr), sodium butyrate (Bu), 0.5% of each sodium salt of acetate and 
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Fig. 5.3. Effect of APP and SCFA on plasma LDL- and HDL-Cholesterol 
level. Male hamsters were fed with normal diet, control diet, short chain 
fatty acids diet (with supplementation of 1% of sodium acetate (Ac), 
sodium propionate (Pr), sodium butyrate (Bu), 0.5% of each sodium salt of 
acetate and propionate (Ac,Pr) and test diet (with supplementation of 2% 
APP) for four weeks. (*P<0.05) 
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Table 5.2. Effect of APP and SCFA on LDL/HDL Cholesterol Ratio. For 
experiment 4，male hamsters were fed with normal diet, control diet (high 
cholesterol diet), test diet (with 2% APP supplementation) and SCFA diets 
(with supplementation of 1% of sodium acetate (Ac), sodium propionate 
(Pr), sodium butyrate (Bu), 0.5% of each sodium salt of acetate and 
propionate (Ac,Pr) for 4 weeks. For experiment 6, male New Zealand 
rabbits were fed with normal diet, control diet and test diet (with 2% APP 
supplementation) for three months. 
LDL/HDL-Cholesterol Ratio 
Experiment 4 Normal Control Ac Pr 
W e e k 4 0.77 1.32 0.74 1.20 
Bu Ac，Pr Test (2%) 
1.22 0.84 0.66 
LDL/HDL-Cholesterol Ratio 
一 Experiment 6 Normal Test (2%) Control 
Month 0 
Month 1 0.50 0.88 3.20 
Month 2 0.56 0.86 3.35 
Month 3 0.43 0.45 1.87 
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Fig. 5.4. The effect of different diets on plasma ALT and AST level. Male 
hamsters were fed with normal diet, control diet, short chain fatty acids diet 
(with supplementation of 1% of sodium acetate (Ac), sodium propionate 
(Pr), sodium butyrate (Bu), 0.5% of each sodium salt of acetate and 
propionate (Ac,Pr) and test diet (with supplementation of 2% APP) for four 
weeks. (* P<0.05) 
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5.2.5 Effect of SCFA supplementation on HMG-CoA Reductase 
Activity 
All groups with supplementation of SCFA or APP showed significant difference 
in HMG-CoA Reductase activity compared with control group (Fig.5.5). The activity 
(pmol/min/mg protein) was decreased by 22.45% (Ac), 25.9% (Pr), 21.4% (Bu), 19.35% 
(Ac,Pr) and 30.95% (test). 
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Fig. 5.5. Effect of APP and SCFA on HMG-CoA Reductase Activity in 
liver tissue. Male hamsters were fed with normal diet, control diet, short 
chain fatty acids diet (with supplementation of 1% of sodium acetate (Ac), 
sodium propionate (Pr), sodium butyrate (Bu), 0.5% of each sodium salt of 
acetate and propionate (Ac,Pr) and test diet (with supplementation of 2% 
APP) for four weeks. (*P<0.05) 
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5.3 Discussion (Exp. 4,5) 
Feeding some dietary fibers lowers plasma cholesterol concentration. The 
mechanism is not flilly understood. It is proposed that cecal and colonic fermentation of 
dietary fiber is associated with cholesterol-lowering effect of fibers (Anderson, 1985; 
Moundras et al, 1995). Study reported that the lowering effect of the fiber disappeared 
when the cecum was resected (Nishimura et al, 1993). This finding shows that the large 
intestine is involved in the reduction of plasma cholesterol in rats fed SBF which is a 
highly fermentable dietary fiber. The fermentation product is SCFAs. Therefore, we 
have examined the effect of artificial SCFA on plasma and liver cholesterol level. The 
results showed that acetic acid, propionic acid, mixture of acetic and propionic acid 
(Hara et al, 1998b) and APP could lower LDL-C but not butyric acid compared to 
control group. However, acetic acid and APP can slightly increase HDL-C and no 
significant difference for other groups. Among the three SCFAs, acetic acid exhibited 
highest degree of cholesterol lowering effect. This results shows that the major SCFA, 
acetic and propionic acids are responsible for the plasma cholesterol reduction. 
Two possible mechanisms are proposed for the ceco-colonic-dependent decrease 
in plasma cholesterol. In the first mechanism, fiber or its fermentation products stimulate 
the large intestine, and humoral factors secreted from the large intestine or enteral 
nervous system modify cholesterol metabolism. Study (Goodlad et al, 1989) showed that 
colonic fermentation of dietary fiber elevates plasma enteroglucagon, and it is known 
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that the large intestine is important for production of this hormone (Kennedy et al, 1982). 
In addition, the enteric nervous system in the large intestine is possibly stimulated by 
fiber or its fermentation products. Some neuropeptides are known to influence 
cholesterol and bile acid metabolism (Cho et al, 1997; Farouk et al, 1992). Therefore, 
we also examined effect of SCFA on the de novo cholesterol synthesis by measuring the 
activity of HMG-CoA Reductase and the liver cholesterol level (Hara et al, 1999). From 
the result, all of the SCFAs and APP can decrease the activity of HMG-CoA Reductase 
activity significantly with similar extent among three SCFAs. Moreover, all three 
SCFAs can decrease hepatic cholesterol significantly compared with control group. The 
results showed that SCFA could decrease de novo cholesterol synthesis and thus liver 
cholesterol level The lowering activity of HMG-CoA Reductase in control group 
compared with normal group was due to the high fat and cholesterol content in the diets. 
The results also showed that mixture of SCFA (acetic and propionic acid) exhibits the 
same effect as individual SCFA. 
Furthermore, we also examined the toxicity of SCFA to liver. The result showed 
that butyric acid could greatly increase more than one fold of AST and ALT activity 
compared to control group. — 
136 
Hypolipidemic and Antiatherosclerotic Effect of APP 
Chapter Six: 
Hypolipidemic and Antiatherosclerotic Effect of APP 
6.1 Introduction (Exp. 6) 
Epidemiological studies have shown a consistent and strongly significant 
correlation between total plasma cholesterol level and incidence of CHD (Stamler et al, 
1986). Both CHD incidence and extent of atherosclerosis autopsy can be explained to a 
large extent by variations in mean total cholesterol levels between populations. Among 
individual within diverse populations, prospective studies of middle-aged men have 
shown a positive relation between CHD risk and total cholesterol level above 200 to 220 
mg/dl (J Chronic.Dis., 31，201-306, 1978). This association may be weak or absent in 
some populations with low mean total cholesterol levels or CHD risk {Circulation, 85, 
1083-1096, 1992). 
Total cholesterol conc entration generally reflects LDL cholesterol level. 
Epidemiological studies between and within population also show a strong relation 
between CHD risk and LDL cholesterol levels (Cerda et al, 1994). A direct relation 
between LDL concentration and extent of coronary atherosclerosis has also been shown 
in several angiographics studies. Furthermore, clinical trials and angiographic studies 
— provide good evidence that reductions in LDL cholesterol are associated with reduced 
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incidence of CHD events and slowed progression of atherosclerotic lesions (Kroon & 
Stalenhoef, 1997). Moreover, HDL cholesterol has inverse relationship with the degree 
of atherosclerosis. 
Dietary cholesterol has been shown to increase atherosclerosis in susceptible 
animal species. The atherogenic effect of dietary cholesterol was first demonstrated in 
rabbits, but has also been observed in several other animals, including pigs, guinea pigs. 
We have employed New Zealand White Rabbits as animal model for testing whether 
supplementation of dietary fiber can stop the progression of atherosclerosis by using a 
high cholesterol diet as control. 
The animals in which diets rich in dietary cholesterol and saturated fat produced 
atherosclerosis also have an increase in plasma cholesterol level in response to these 
diets. There is a strong positive correlation between changes in serum cholesterol level, 
especially LDL cholesterol level, and the development of atherosclerosis in these 
experimental models (McGill, Jr. et al, 1981a; McGill, Jr. et al, 1981b). An inverse 
relation between HDL level and atherosclerosis has been demonstrated in animals (Lusis 
et al, 1983) as well as in humans. In some species, such as rabbits, the diet-induced 
increase in plasma cholesterol level is due mainly to an increase in renmanent 
lipoprotein. However, this increase is seen, but to a lesser extent, in humans consuming 
similar diets. Therefore, we decided to make a relationship between LDL/HDL-C ratio 
to the degree of atherosclerosis. Increased ratio of LDL/HDL may increase the 
development of atherosclerosis as expected (Chait et al, 1993). 
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6.2 Results (Exp. 6) 
6.2.1 Body Weight and Food Intake 
From Table 5.1, the food intake of test and control group has no significant 
difference. However, the food intake of normal group was 14.23% and 14.29% 
significantly higher than test group and control group respectively. The average food 
intake was low in both test and control group as the food intake was decreased with time. 
The weight gain was 0.2 Kg and 0.15 Kg in normal and test group respectively. 
However, control group has weight loss of 0.24 Kg. 
From Table 4.1，there was a large difference of the average liver weight between 
normal group (75.47 g) and test group (112.35 g) or control group (127.23 g). The 
average liver weight of test group was 11.7% lower than control group. 
6.2.2 Effect of APP Supplementation on Hepatic Cholesterol 
From the results, liver cholesterol level was decreased significantly by 14.08% 
in test group compared with control group as shown in Fig. 6.1. However, the liver 
cholesterol level of test group and control group was more than 10 folds higher than 
normal group. 
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Fig. 6.1. Effect of APP on liver cholesterol level in rabbit. Male New 
Zealand rabbits were fed with normal diet, control diet and test diet (with 
supplementation of 2% APP) for three months. (*P<0.01) 
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6.2.3 Effect of APP Supplementation on Plasma TG, HDL- and LDL-C 
Among the three months, the plasma TG level of both test and control group was 
significantly much higher than normal group. At the month 0 and 1, there is no 
significant difference between test and control group. The TG level in test group was 
21.3% and 26.7% significantly lower than control group at month 2 and 3 respectively 
as shown in Fig. 6.2. For both HDL-C and LDL-C, normal group has a much lower level 
than control and test group. Except at month 0，LDL-C of test group showed a 
significantly lower level than control group at month 1, 2 and 3. Except at month 0， 
HDL-C of test group showed a significantly higher level than control group at month 1, 
2 and 3. HDL-C was increased by 105.66%, 89.97% and 67.42% in test group at month 
1, 2 and 3 respectively compared with control group. LDL-C was decreased by 43.67%, 
50.96% and 59.25% in test group at month 1, 2 and 3 respectively as shown in Fig. 6.3. 
The LDL/HDL ratio of this experiment was shown in Table 5.2. The average ratio 
among three months was 0.54 土 0.11, 0.73 土 0.20 and 2.27 土 1.26 in normal, test and 
control group respectively. However, this average value cannot represent the 
cardiovascular status of the rabbit. The change of ratio with time was more important. 
For normal group, this ratio does not fluctuate greatly. At month 0，there was no 
significant difference among three groups. For test group, the ratio was increased by 
18.920/0 and 16.22% at month 1 and 2 respectively compared with month 0. However, 
the ratio was dropped to a level even lower than the ratio at month 0. For control group, 
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the ratio was increased by 384.85% and 407.58% at month 1 and 2 respectively 
compared with month 0. However, the ratio was dropped by 44.18% compared with 
month 2. At month 3，there was no significant difference of LDL/HDL ratio between 
normal and test group. However, control group has a ratio of 334.88% higher than 
normal group. 
6.2.3 Effect of APP Supplementation on AST and ALT Activity 
From Fig. 6.4, there is no significant difference for ALT activity between test 
and normal group. The ALT activity of control group was always higher than both test 
and normal group. However, there was a drop in activity in control group to the level of 
test group at month 2. At month 1，ALT activity of the test group was decreased by 
37.77% significantly as compared with control group. For AST activity, the level of 
control group was always higher than both test and normal group. With similar 
phenomenon to ALT activity, there was no significant difference among three groups at 
month 2. Test group showed a significant decrease in AST activity by 42.84% and 
47.31% at month 1 and 3 respectively. 
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Fig. 6.2. Effect of APP supplementation on plasma triglyceride level. Male 
New Zealand rabbits were fed with normal diet, control diet and test diet 
(with supplementation of 2% APP) for three months. (* P<0.05) 
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Fig. 6.3. Effect of APP supplementation on plasma HDL- and LDL-
cholesterol level. Male New Zealand rabbits were fed with normal diet, 
control diet and test diet (with supplementation of 2% APP) for three 
months. (* P<0.01) 
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Fig. 6.4. Effect of APP supplementationThe effect of different diets on 
plasma ALT and AST level. Male New Zealand rabbits were fed with 
normal diet, control diet and test diet (with supplementation of 2% APP) for 
three months (* P<0.05). 
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6.2.5 Effect of APP supplementation on HMG-CoA Reductase Activity 
Fig. 6.5 showed the HMG-CoA Reductase activity (pmol/min/mg protein) of 
normal (50.23), test (40.33) and control (43.43) group. The activity in normal was higher 
than both the test and control groups; while test group with 7.14% lower activity than 
control group (P<0.05). 
6.2.6 Effect of APP supplementation on the Formation of Atheroma 
The photographs of representative aortas in normal, test and control group were 
shown in Fig. 6.6. The regions stained red are represented to atheroma. By general 
observation, the area of atherosclerotic lesion is the highest in control which receive 
high cholesterol diet. In test group, there is still a small degree of lesion but it showed a 
regression of atherosclerosis compared with control group. By analysis of the area 
covered by atherosclerosis, the average value of percentage area covered was 8.80%, 
24.85% and 58.51% in normal, test and control group respectively. All of the rabbit 
were fed for three months with different diet. 一 
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Fig. 6.5. Effect of APP supplementation on liver HMG-CoA Reductase 
level in rabbit. Male New Zealand rabbits were fed with normal diet, 
control diet and test diet (with supplementation of 2% APP) for three 
months. (* P<0.05) 
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Fig. 6.6. Photograph of representative aortas of rabbit receiving an 
atherogenic diet showing decreased aortic atherosclerosis receiving 
supplementation of APP. Rabbits were fed with normal diet without 
supplementation of cholesterol, test diet with supplementation of 1% 
chptesterol and 2% AEP m d control diet with only supplementation of 1% 
chofesterol. 
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Treatment Aorta 
% Area Covered by Atherosclerosis 
Normal 8.80 土 5.95 
Test (with 2% APP) 24.85 土 7.70 
Control (without APP) 58.51 士 17.19 
Table 6.1. Percentage of area covered by atherosclerosis in aorta in normal, 
test and control group. Normal diet contains no cholesterol. Test diet was a 
high cholesterol (1%) diet with supplementation of 2% APP. Control diet 
was only a high cholesterol (1%) diet. 
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Normal Test Control 
Fig. 6.7. Photographs of rabbit liver. Rabbits were fed with normal diet 
without supplementation of cholesterol, test diet with supplementation of 
1% cholesterol and 2% APP and control diet with only supplementation of 
1% cholesterol. The liver was harvested after three months treatment. 
：i ’ 
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6.3 Discussion (Exp. 6) 
Hypercholesterolemia is a major risk factor in the development of atherosclerosis 
{JAMA, 253, 2080-2086, 1985; Ross, 1986) and cholesterol-lowering agents are used in 
selected patients to retard atherogenesis. As an alternative to the use of pharmaceutical 
agents, recent studies have shown that ingestion of water-soluble dietary fibers such as 
oat bran or pectin will lower cholesterol levels (Keys et al, 1961; Anderson et al, 1988). 
APP is also a water-soluble dietary fiber and the results showed that it has 
hypocholesterolemic effect. As a dietary supplement, APP reduces liver cholesterol 
levels (Keys et al, 1961; Kay & Tmswell, 1977; Cerda et al, 1988) and lowers low-
density lipoprotein (LDL) cholesterol. On the contrary, it can increase high-density 
lipoprotein (HDL) cholesterol and as a result, has a much lower LDL/HDL cholesterol 
ratio that is a good index of atherosclerosis. However, APP has little triglyceride 
lowering effect. Moreover, it does not show any toxic effect on liver cells as the AST 
and ALT activity was lower in test group compared with control group. 
During the experimental period, we examined the external health status of the 
_ rabbits. For the control group without APP supplementation, the body weight of rabbits 
were dropped instead of weight gain and also the food intake was decreased. By 
observing the appearance of the liver, the control group with high cholesterol diet 
showed a pathogenic effect on liver. The rabbits of control group have some kinds of 
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jaundice as seen in Fig. 6.7. Therefore, we found that rabbit is an animal model that was 
very sensitive to dietary composition. 
The pathogenic effect of liver was due to high concentration of cholesterol 
accumulation. High cholesterol diet lowered the liver cholesterol synthesis by down-
regulating the HMG-CoA Reductase activity. APP can further lower the enzyme activity 
compared with the control group. High hepatic cholesterol in test and control group was 
mainly due to the intake of high cholesterol diet. The decreased hepatic cholesterol in 
test compared with control group may due to decrease in HMG-CoA Reductase activity. 
However, the underlying mechanism that APP can decrease the activity of HMG-CoA 
Reductase activity was unclear. 
Very little is known about the effect of dietary fiber (APP) on atherosclerosis 
(Cerda et al, 1994). However, we can conclude that APP either regressed or prevented 
the development of atherosclerosis as it substantially reduced the aorta area occupied by 
atheromatous plaques. 
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Chapter Seven 
General Discussion and Future Perspectives 
Auricularia polytricha is an edible fungus which is a popular foodstuff in 
Oriental countries. This type of fungus is in the members of Auriculariaceae family. It 
has gelatinous fruiting bodies when it is fresh. It always sold in dry stuff in Chinese 
medicine store. This fungus was claimed to have hypolipidemic effect but without 
detailed experimental investigations. 
The water-soluble fractions extracted from Auricularia polytricha was found to 
contain mainly polysaccharides which consist of mainly mannose, glucose and galactose 
as its monosaccharide. It was predicted to contain mainly glucomannan, galactomarman 
and glucogalactomannan. It showed a high solubility, viscosity and water-holding 
capacity. From the size-exclusion chromatography, Auricularia polytricha 
Polysaccharide (APP) was a heterogeneous mixture of water-soluble dietary fiber that 
has different molecular size. However, there is no information for its molecular structure. 
In order to have a clear picture of the structures, data from IR, NMR and even X-ray 
crystallographic analysis should be obtained. 
From the results of the experiment, fasting plasma total cholesterol and low-
density lipoprotein (LDL) cholesterol were lowered by supplementation of 2% of APP. 
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However, the high-density lipoprotein (HDL) cholesterol was increased or remains 
unchanged. Furthermore, the plasma triglyceride level fluctuated and there is no 
significant increased or decreased in TG level compared with control group. 
For the protective study, a high cholesterol (0.5%) diet with supplementation of 
2% APP was used to test whether APP can prevent the rise of plasma cholesterol level. 
The results showed that APP can lowered plasma cholesterol level and hepatic 
cholesterol level. Therefore, APP can protect body from hypercholesterolemia. 
For the therapeutic study, hamsters were boosted into hypercholesterolemic 
status by feeding it with a high cholesterol diet. After 4 weeks, hamsters were fed with 
high cholesterol diet with supplementation of 2% of APP. After 4 weeks, the 
hypocholesterolemic effect of APP was not obvious but with some improvement. Eight 
weeks after supplementation of APP, the improvement was obvious and LDL-
cholesterol was decreased by 47.1% compared to control group. Also, the liver 
cholesterol was decreased by 26.3% significantly. Therefore, APP can even lower 
cholesterol level in a pre-hypercholesterolemia body. For the dose-dependent response 
study, we try to use different amount of APP to see whether increased amount of APP 
can further improve hypercholesterolemia. The results showed that there is no dose-
dependent response in plasma cholesterol level. However, there is a dose-dependent 
response in liver cholesterol level. The percentage of APP showed a linear relationship 
with liver cholesterol. Liver cholesterol decreased with increased percentage of APP 
supplementation. Moreover, by assay the activity of AST and ALT, APP does not show 
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any toxic effect toward liver. Similar activity was observed for increased percentage of 
APP supplementation. 
APP was a water-soluble polysaccharide that can resist degradation from 
digestive enzyme. It can probably reach ceco-colonic region and degraded by anaerobic 
bacteria and produce short chain fatty acids (SCFA) (Treem et al, 1996). These fatty 
acids included mainly acetic acid, propionic acid and butyric acid that was claimed to 
have hypocholesterolemic effect. Therefore, the hypocholesterolemic effect of APP may 
be due to by-products of fermentation. In the experiment, we use artificial SCFA to test 
its hypocholesterolemic effect. As expected, the result showed that SCFAs have 
hypocholesterolemic effect with descending potency of acetic acid, propionic acid and 
then butyric acid. Experiment must be decided in future to prove whether APP can be 
fermented to produce SCFA (Daniel et al, 1997; Itoh & Mitsuoka, 1985) and compared 
the effect of fermented products with APP. 
In experiment 5, the effect of APP and SCFA on HMG-CoA Reductase activity 
was tested. Both APP and SCFA can decrease the activity of HMG-CoA Reductase. 
Therefore, the de novo cholesterol synthesis was decreased with decreased in this 
enzyme activity. However, in the future, the activity of the enzyme (cholesterol 7-alpha 
hydroxylase) that convert hepatic cholesterol into bile acid must be assayed (Schmitz & 
McDonald, 1974; Jelinek et al, 1990). It is because bile acid is the only way that 
cholesterol can be excreted out of the body via feces. Therefore, increased activity of 
this enzyme can significantly decrease the pool of hepatic cholesterol. 
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Proposed mechanism included binding of steroids with water-soluble dietary 
fiber (Spiller, 1996). Therefore, we have determined the neutral and acidic sterol from 
feces output. In this mechanism, dietary fiber was acted as non-systemic agent (Story et 
al, 1997). However, in vitro experiment is difficult to conduct as the extracted 
polysaccharide was water-soluble (Ebihara & Schneeman，1989). Excess bile acid was 
added for binding. However, there is a problem with the elimination of unbound bile 
acid. In experiment 1 and 3, APP can slightly increase the neutral steroid excretion and 
greatly increase the acidic steroid excretion. However, the dose of APP has no effect on 
both fecal neutral and acidic steroids excretion. 
In experiment 6, we tested the antiatherosclerotic effect of APP. We can develop 
a relationship between plasma cholesterol level and degree of atherosclerosis. LDL-
cholesterol was shown to have direct relationship with atherosclerosis while HDL-
cholesterol has inverse relationship. Therefore, we used LDL/HDL ratio to construct a 
relationship with the degree of atherosclerosis. The degree of atherosclerosis was 
determined by the formation of atheroma that is stained by a lipophilic dye, Sudan III. 
The results showed that LDL/HDL-cholesterol ratio is much higher in control group 
than in test group. Moreover, the aortic area occupied by atheromatous plaques was 
much higher in control group. Therefore, we can conclude that APP can regress or 
prevent the development of atherosclerosis and there is a good relationship between 
LDL/HDL-cholesterol ratio and degree of atherosclerosis. Ratio was increased with the 
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higher probability of development of atherosclerosis. Therefore, APP may modify the 
lipoprotein profile in order to prevent formation of atherosclerosis. 
Up to now, the hypocholesterolemic effect of dietary fiber was complicated and 
its detail mechanisms are still unclear. The hypocholesterolemic and antiatherosclerotic 
effects may be due to combined mechanisms and so more experiments must be decided 
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